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Abstract: 
We compare patent litigation cases across four European jurisdictions – Germany, 
France, the Netherlands, and the UK – covering cases filed during the period 2000-
2008. For our analysis, we assemble a new dataset that contains detailed information 
at the case, litigant, and patent level for patent cases filed at the major courts in the 
four jurisdictions. We find substantial differences across jurisdictions in terms of case 
loads. Courts in Germany hear by far the largest number of cases in absolute terms, 
but also when taking country size into account. We also find important between-
country differences in terms of outcomes, the share of cases that is appealed, as well 
as the characteristics of litigants and litigated patents. A considerable number of 
patents are litigated in multiple jurisdictions, but the majority of patents are subject to 
litigation only in one of the four jurisdictions. 
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1 Introduction 
At present, the European patent system is undergoing a series of major reforms centered on 
the idea of “unifying” (or rather defragmenting) the European patent system. These reforms 
are currently moving ahead briskly - in December 2012 the European Parliament approved 
the so-called EU unitary patent package.1 One major reason for reforming the current 
enforcement system was the existence of some duplicative, and even in some cases 
contradictory, patent enforcement decisions across jurisdictions within Europe.2  Once 
ratified by the individual member states, the agreement will create a European patent with 
unitary effect (or unitary patent) in all jurisdictions which have acceded to the measure. This 
will allow patent protection for all participating EU Member States on the basis of a single 
application and validation, i.e., there will no longer be a need to separately validate the 
patent once granted by the European Patent Office (EPO) in each state via the payment of 
validation fees at the national patent offices.3  
The unitary patent complements the existing patent system in Europe, a system which 
allows the co-existence of patents granted by national patent offices as well as patents 
granted by the EPO, which can be validated in one or more countries which are signatories 
to the European Patent Convention (EPC). In contrast to European Patents (EP) granted by 
the EPO which then are validated in the member states of the EPC where they are subject to 
national law (Art. 2(2) EPC and Art. 64(1) EPC), the unitary patent will be subject to the same 
legal conditions in all member states. Toward this aim, an integral part of the new package is 
the creation of the Unified Patent Court (UPC). The UPC will have exclusive jurisdiction with 
respect to unitary patents as well as (after a transitional period) European (i.e. EPO-granted) 
patents designating one or more member states. The court consists of a central division as 
well as local and regional divisions. The agreement places the seat of the UPC's central 
division in Paris. Specialized units of the UPC’s central division will be set up in London 
(chemical and pharmaceutical patents) and Munich (mechanical engineering). Generally, 
claimants will bring actions for revocation before the central division, and will bring actions 
for infringement before a local/regional division in a member state in which the 
infringement has occurred, or where the defendant is domiciled. One aspect of the reform 
that marks a considerable change for some jurisdictions is that the system allows for a 
choice between bifurcation and an integrated process for hearing infringement and 
invalidity cases. Currently, bifurcation, i.e., the separation of infringement and validity 
claims into separate court actions, is used in few European countries. By giving local or 
                                                        
1
 See http://www.europarl.europa.eu/sides/getDoc.do?type=IM-PRESS&reference=20121210IPR04506&forma 
t=XML&language=EN (last visited 23.09.2013). For the relevant legislation see: 
http://ec.europa.eu/internal_market/indprop/patent/documents/index_en.htm (last visited (25.09.2013); for 
an explanation of the changes see: http://www.epo.org/law-practice/unitary.html (last visited 25.09.2013). 
2
 See Harhoff (2009, p. 38-40). 
3
 Spain and Italy are the only EU member countries not participating in the Unitary Patent package. 
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regional courts of the new UPC the discretion to refer counterclaims for revocation to the 
central division, either bifurcation or integrated treatment of cases may be used. 
The approval by parliament was preceded by a drawn-out, highly controversial debate 
involving policy makers, academics, and practitioners. The main concerns commentators 
had with the proposed reform centered on the ability of the package to actually reduce the 
fragmentation of the European patent system and to in practice lower the costs for judicial 
proceedings (thereby making access to courts easier for smaller companies) without 
creating incentives for welfare-reducing litigation activities. Some of these issues remain 
controversial, especially the issue of choice of venue, which is to be taken by claimants, and 
the issue of which official language ought to be used during the action. There are also a 
number of practical issues that need to be resolved, such as the number of local divisions in 
each jurisdiction and the composition of judiciary panels.4 
It is clear that the debate concerning the UPC is characterized by the presence of an 
enormous amount of often controversial anecdotal evidence and conversely, an astonishing 
lack of insights derived from actual empirical data analysis. To some extent this is explained 
by the fact that systematic and comparable data concerning patent litigation in Europe has 
been thus far unavailable. This stands in stark contrast to the U.S. where extensive empirical 
evidence on patent litigation exists. However, up to this point there exists no systematic 
comparison of litigation across European jurisdictions which would allow a proper 
evaluation of the need for specific reforms or the likely impact such reforms may have on 
outcomes. For example, an important argument put forward by the proponents of the UPC 
is that it will reduce forum shopping5 in Europe.6 Nonetheless, it is plausible that the UPC 
may give rise to a new type of forum shopping if local divisions differ systematically in their 
willingness to grant pan-European injunctions and/or to separate the infringement and 
validity proceedings. However, to date no comprehensive statistics exist on the 
pervasiveness of cross-border litigation and forum shopping that would enable a proper 
assessment of the merits of the argument in favor of creating the UPC in the first place. Nor 
is it clear that the creation of the UPC will necessarily improve welfare.  
We aim to address this lack of empirical evidence by shedding light on patent litigation 
within the fragmented patent enforcement systems in Europe over the period 2000-2008.7 
                                                        
4
 For a current draft of the Rules of Procedure see http://www.unified-patent-
court.org/images/documents/draft-rules-of-procedure.pdf (last visited 23.09.2013). 
5
 Forum shopping refers to the strategic choice of court venue by litigants to obtain a favorable outcome (see 
Moore (2001), p. 899). This also includes the strategic choice to litigate in several jurisdictions and to use 
favorable judgments in one jurisdiction to influence the outcome in another jurisdiction. 
6
 See for example EPO http://www.epo.org/law-practice/unitary/patent-court.html (last visited 22.04.2013). 
7
 The objective of this study is to cover all patent cases filed at the courts covered by our investigation during 
the period 2000-2008. These cases may have been decided after 2008; since our data collection occurred 
between 2010 and 2012, decisions after 2008 are covered. In its current form, the data for the Netherlands 
and France do not cover all cases filed, but are largely restricted to cases that were adjudicated. 
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We draw a direct comparison between patent litigation in four legal systems in Europe: 
Germany, the UK (England and Wales), France, and the Netherlands. These countries handle 
the majority of all patent cases in Europe, and are therefore the most relevant ones for this 
study.8 
It is notable that there are important differences in the legal systems across these 
jurisdictions, something that makes assembling a comparative analytical report a 
challenging task. The most obvious difference among these four systems is that the German 
system is bifurcated whereby infringement and validity are handled separately at different 
courts. The other three systems combine both issues in the same court action. Since the 
UPC allows for bifurcation, as briefly described above, insights from a comparison of 
litigation in Germany with litigation in the other countries, which do not feature bifurcation, 
ought to yield some useful insights with regard to the overall functioning of the UPC. There 
are also important institutional and procedural differences across jurisdictions, which 
account in part for the concentration of cases involving certain technologies in a given 
jurisdiction. For example, we show that pharmaceutical cases and technologies related to 
telecommunication and digital data transmission are litigated disproportionately more 
frequently in the UK (i.e. as a share of the total caseload in the UK) whereas cases related to 
machinery and engineering more broadly are litigated mostly in Germany.  
For our analysis, we have collected case-level patent litigation data directly from court 
records and a range of other sources in all four countries for the period 2000 to 2008. We 
have collected the data in a harmonized way to ensure comparability, which is a major 
challenge in the analysis of litigation data across jurisdictions. We further added information 
on the characteristics of the litigated patents and litigating parties from external databases 
to complement our case-level analysis. 
The results point to a number of differences in litigation patterns and outcomes across the 
four jurisdictions, some of which challenge the conventional wisdom derived from anecdotal 
case-by-case evidence. Note that due to concerns over the completeness of the data for 
France and the Netherlands, we emphasize the comparison between Germany and the UK 
throughout our analysis. 
With regard to case-level analysis, we show that the number of court cases differs 
substantially across jurisdictions. Although comparing case counts across jurisdictions is 
difficult, especially between a bifurcated and a non-bifurcated system, the data still indicate 
that a substantially larger number of patent cases is heard by regional courts in Germany 
than in any of the other jurisdictions. Depending on how cases are counted in Germany, the 
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 For an overview of the number of cases see European Council 2007 WD 11622/07 PI 135. For the relevance of 
the four jurisdictions for patent litigation in Europe see Taylor Wessing 2009 Global Intellectual Property Index 
Report at http://www.taylorwessing.com/ipindex (last visited 23.09.2013). 
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total caseload in Germany is between 12 and 29 times larger than in the UK.9 The data for 
different regional courts in Germany reveal that caseloads differ enormously even within a 
single jurisdiction. The regional court in Düsseldorf hears more than seven times as many 
cases as the regional court in Munich. 
Our data also allow us to compare across jurisdictions how long it takes courts to reach a 
first decision on the merits of the case. Proceedings take around two years in France, but 
are substantially faster in the other three jurisdictions. Median durations for infringement 
cases are 9 months in Germany, 10 months in the Netherlands, and 11 months in the UK. 
The fact that we possess detailed information for cases in the UK allows us to gauge 
whether decisions in Germany are relatively fast because of the fact that in the German 
system courts decide only on either infringement or revocation. This is done by looking only 
at cases in the UK where no attack on the validity was raised (neither as defense nor as a 
counterclaim) and hence, where the court focused solely on the claim brought by the 
claimant. Interestingly, our results indicate that focusing on a single issue does not appear 
to have any substantial effect on the median duration of a case in the UK. Nevertheless, if 
the validity of a patent is challenged in Germany at the Federal Patent Court, the judgment 
of the validity case is commonly handed down with a substantial lag relative to the 
judgment of the infringement case. Therefore, the total length of an infringement case in 
Germany if the alleged infringer challenges validity at the Federal Patent Court takes a lot 
longer (on average 24 months) because the invalidity challenge is usually filed a few months 
into the infringement case.10 
The data also reveal substantial differences across jurisdictions in the outcomes of cases 
that were decided by a judgment on the merits of the case. For example, the UK stands out 
with a relatively large share of revoked patents, even when the original claim is for 
infringement. In Germany, the share of patents involved in an infringement suit that were 
revoked by the Federal Patent Court is low, at a mere 6%. However, this reflects partly the 
fact that only in around a third of infringement cases the defendant files a claim for 
revocation with the Federal Patent Court. 
Another interesting finding of our case level analysis is the relatively large share of first 
instance cases in the UK that is appealed. We find that almost 50% of revocation and 
infringement cases proceed to the Court of Appeal. But the 1st instance decision is 
overturned only in a quarter of such appeals in the UK. In Germany, by contrast, the share of 
cases that proceed to the higher regional courts is a lot lower (15% of infringement and 10% 
                                                        
9
 However, as discussed in the Conclusion, data on recent case filings in the UK in 2012 point to a very 
substantial increase of the caseload in the UK. 
10
 The fact that invalidity claims can only be filed at the Federal Patents Court after an opposition at the 
German Patent and Trademark Office (DPMA) or the EPO (or after the period for an opposition has expired) 
may further delay the decision on validity. 
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of revocation cases) and the share of judgments that is overturned is with 16% even lower 
than in the UK. 
Our analysis also offers evidence on the fragmentation of the European patent system. In 
UK and the Netherlands we find a relatively high number of cases that are litigated in 
several jurisdictions (26% and 15% of all cases litigated in the UK and the Netherlands 
respectively). These shares are a lot lower in Germany (2%) and France (6%). The lower 
shares are also explained by the fact that the overwhelming share of patents litigated in the 
UK and the Netherlands are national parts of EP patents (81% and 73% respectively) that 
have also been validated in Germany and France. The share of litigated EP patents is a lot 
lower in Germany and the Netherlands (42% and 39% respectively). If we restrict attention 
to EP patents only, overall the incidence of duplication is small: only 8.4% of all litigated EP 
patents are subject to litigation in more than one country. Of course, the patents affected 
by duplicated litigation are likely to be particularly important, and the cases will be more 
resource-intensive than those for other patents. 
Regarding analysis at the litigant level, the detailed information on the litigating parties we 
possess enables us to compare their characteristics across jurisdictions. In all jurisdictions 
we find that litigants are distributed over a wide range of industries. Nevertheless, 
pharmaceutical companies are overrepresented as litigants within the UK legal system. In 
Germany, there are disproportionately many litigants in the machinery industry. In the 
Netherlands the presence of many companies in the finance and insurance business is 
notable. In France, by contrast, litigation does not appear to be concentrated in any specific 
industry. The sector distribution of litigants matches the distribution of litigated patents 
across broad technology areas. Thus, it can be said that most patents litigated in the UK are 
related to chemicals and pharmaceuticals (31%), whereas most of the litigated patents in 
Germany are in the areas of mechanical and civil engineering (33%).  
Finally, with respect to patent-level analysis, a comparison of patent characteristics across 
jurisdictions reveals that the patents litigated in the UK appear to be more valuable 
(according to patent characteristics widely used in the literature such as family size and the 
number of inventors) and broader (measured by the number of IPC subclasses) than the 
patents litigated in the other jurisdictions. This fact is especially significant in light of the 
high revocation rate in the UK. 
The remainder of this paper is organized as follows. Section 2 contains a review of the 
existing empirical evidence on patent litigation in Europe. Section 3 describes the 
enforcement systems in all four countries. Section 4 discussed differences in the legal 
systems in more detail. In Section 5 we describe the collection of our litigation data and the 
construction of the dataset used in our analysis. Section 6 contains our comparison of 
litigation across European jurisdictions. Section 7 offers some brief concluding thoughts. 
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2 Literature review of empirical evidence on patent litigation 
In this section, we briefly review the available evidence on patent litigation in Europe. As will 
become evident from reading the descriptions below, the available evidence on patent 
litigation is scarce, especially in comparison to the empirical evidence available for the U.S. 
Nonetheless, as shown below, it is clear there are significant jurisdictional differences 
between the various legal systems which may have important implications for patent 
enforcement in practice. 
Germany 
For Germany, the first attempt to systematically analyze patent infringement cases was 
made by Stauder (1983 and 1989). He collected data on patent and utility model cases filed 
between 1971 and 1973 in Germany and described litigation patterns, their outcomes and 
duration from a comparative law point of view. Meanwhile, Hase (1992; 1993; 1994) 
obtained data on patent cases at nine regional courts for 1990, 1991, and 1994.11 Hase’s 
objective was to show the absolute number of cases and their distribution across courts. 
The data reveal a highly skewed distribution of the caseload: in 1990, Düsseldorf and 
Munich account for 35% and 22% of all patent cases, respectively; that is two out of nine 
courts account for slightly less than 60% of cases. More recently, Kühnen and Claessen 
(2013) collected information on case counts at the regional courts in Düsseldorf and 
Mannheim for 2009-2011. Their data suggests that Düsseldorf and Mannheim are the most 
important courts in Germany for patent infringement. The authors estimate that they 
accounted for almost 40% of all infringement cases in Germany in 2011. 
Cremers (2007) collected data from court archives of the specialized intellectual property 
(IP) chambers in Mannheim and Düsseldorf for the case filing years 1993-1995. Her sample 
contains a total of 715 patent cases concerning 910 litigated patents and utility models. The 
filing dates of these patents range between 1978 and 1993. Cremers analyzes the 
determinants of patent litigation by comparing the litigated patents to a control sample of 
non-litigated patents. Cremers demonstrates that the most valuable patents are more likely 
to be the subject of litigation. In addition, she finds smaller firms are more likely to be 
involved in litigation, and further to this, that the litigation probability decreases with the 
portfolio size of the patentee. Using the same database as in her 2007 paper, Cremers 
(2009) investigates the settlement decisions in patent infringement suits. She shows that 
legal differences between the regional courts have a significant impact on the settlement 
rates during trial. Cremers further finds that, at later stages of the trial, the use of invalidity 
suits positively affects the settlement probability, while the fact that a patent has survived 
an opposition procedure generally increases the settlement probability. Cremers and 
Schliessler (2012) use data on patent litigation at the three most important regional courts 
                                                        
11
 The data differ across years. Whereas the data for 1990 refer to cases concluded in 1990, the data for 1991 
and 1992 refer to the number of cases filed in that year. 
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Mannheim, Munich and Düsseldorf in 2000-2008 (see Section 3.1 below)12 to find that new 
information revealed during trial has a positive effect on settlement probability. Further 
research on the effects of litigation on companies’ behavior and strategies is provided by 
Schliessler (2013). She looks at the effect of litigation outcomes on firm value. Her results 
suggest that litigation has a measurable impact on firm value, but that this effect depends 
on the characteristics of the parties and the outcome of trial. Defendants are negatively 
affected by a loss or a settlement, while a win leaves the value unchanged. 
UK 
Regarding existing empirical evidence in the UK, Moss et al. (2010) examine the outcomes of 
47 validity and infringement cases between January 2008 and August 2009 by the Patents 
County Court (PCC), the Patents Court (PHC), the Court of Appeal (CA), and the House of 
Lords. 18 out of these 47 cases (38% success rate) were won by the patentee, which means 
that the patent was considered to be infringed and/or valid.  
Meanwhile, Greenhalgh et al. (2010) collect survey evidence on about 100 patenting and 
non-patenting firms (active between 2002 and 2009) to investigate the IP litigation activity 
of micro firms and small and medium-sized enterprises (SMEs) in the UK. They find 
approximately 40% of patent holding firms to have been involved in some kind of IP dispute 
during the five years before the survey. Firms that do not hold patents are much less likely 
to be subject to a patent dispute due to alleged infringement (7% report a dispute). 
Greenhalgh et al. (2010) also demonstrate that firms were as likely to be involved in a 
dispute with another firm of the same or smaller size as they were with a larger company. 
The survey also offers some insight with regard to disputes that never made it to court, i.e. 
regarding the size of the “litigation iceberg that lurks under water.” Greenhalgh et al. (2010) 
find that the vast majority of firms first attempts to resolve a dispute through the exchange 
of letters between solicitors, which appears to resolve a substantial fraction of the disputes. 
Only about 13% of disputes ended up in court. The study also offers some insights with 
regard to the obstacles to litigation. Firms stated that financial costs, in particular legal fees, 
were the principal obstacle to litigation. On top of the direct financial costs, firms expressed 
concerns regarding the time managers and engineers involved in R&D have to devote to 
litigation, effectively diverting scarce resources from more productive activities. Despite the 
high costs of litigation, only about 25% of firms have IP insurance as ex ante it is considered 
too costly by firms, and some firms also expressed concerns that insurers might press for 
early settlement where, on balance, the odds for winning the case were not sufficiently in 
their favor.  
Helmers and McDonagh (2013a) use the data for England and Wales described in more 
detail in Section 3.2 below to provide a more comprehensive analysis of all patent cases 
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 Their data and the data used by Schliessler (2013) orginate from an earlier version of the dataset used in this 
paper. 
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heard by the PCC (2007-2008) as well as filed at the PHC (2000-2008). Their data also cover 
all appeals made to the CA and the House of Lords/Supreme Court. The analysis of the IP 
cases heard before the PCC indicates that patents are the least litigated IP right at the PCC. 
Only 12 out of 64 IP cases concluded in 2007 and 2008 involved a patent. Interestingly, all 
patent cases heard by the PCC are about the infringement of a patent, whereas only half of 
all patent cases before the PHC are infringement actions (i.e. where the claimant alleges 
infringement). It is also noteworthy that the vast majority of claimants at the PCC are small 
firms, whereas there are a disproportionate number of large firms among the defendants. 
At the PHC Helmers and McDonagh (2013a) find 256 patent cases out of a total of 407 IP 
cases filed 2000-2008 (63%), of which 125 resulted in a judgment. They find that about 50% 
of all cases are filed alleging the infringement of a patent and around 37% of filed cases seek 
the revocation of a patent.13 With respect to the 125 judgments, the data show that 
revocation was the most likely outcome regardless of the initial claim – there was an overall 
invalidation rate of approximately 50%. Helmers and McDonagh (2013a) find that most 
litigating companies are in the chemical and pharmaceutical industry and consequently 
most litigated patents protect chemical and pharmaceutical inventions.  
In a companion paper Helmers et al. (2013) use an extension of the data which also includes 
2009 and 2010 to study litigation involving so-called patent trolls (or non-practicing entities 
– NPEs) at the PHC. The authors show that NPEs are relatively uncommon when compared 
to other jurisdictions such as the U.S.: only 11% of patent cases filing during 2000-2010 
involved a NPE, where a substantial number of these cases were between the same parties. 
In most cases, NPEs did not sue for infringement but manufacturers attempted to “clear the 
way” by bringing patent revocation cases before the court. Given the fact that revocation of 
the patent is the most likely outcome of a patent case which reaches judgment in the UK (as 
shown in Helmers and McDonagh, 2013a, Table 12) this indicates that NPEs may seek to 
avoid litigation before the PHC, while companies that are sued by NPEs in other jurisdictions 
may find it advantageous to challenge the validity of the NPE patent at the PHC. In NPE 
cases, ICT-related companies are overwhelmingly involved and NPE patents tend to be ICT-
related. 
France 
Véron (2001) presents data on patent litigation in France for the period 1990-1999. 
According to his data, around 50% of all patent cases during that period are heard by the 
Paris court. Véron (2001) analyzes the data for Paris in more detail to show that 82% of 
patent cases claim infringement, the remainder is mostly related to employee inventions 
and breach of contract. Almost three quarters of litigating parties are French; German and 
U.S. litigants dominate the group of foreign litigants. His data also reveal that 
disproportionately many patents on electronics and instruments are litigated in the Paris 
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 In 61% of infringement actions the defendants file a counterclaim for revocation and in around 41% of 
revocation actions the defendants file a counterclaim for infringement. 
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court. The data on case outcomes show that in around 50% of cases the patent is held valid 
and infringed, revocation occurs only in 23% of French and 15% of EPO patents. Véron 
(2001) has also information on damages. These data show that most damages awarded are 
below Euro 80,000, although there are also eight cases with damages above Euro 1,000,000. 
In a follow-up study, Véron (2010) presents data for 2000-2009. The data indicates that on 
aveage around 335 cases were filed annually between 2004 and 2009 across all courts in 
France that deal with patent cases. Véron finds that 81% of claims filed between 2000 and 
2009 are for infringement. The remainder is relatively evenly distributed across a range of 
other claims such as invalidity or employee inventions. More detailed information on 
decisions on infringement claims at the TGI Paris reveals that infringement was found in 
33% of decisions, in 40% the patent was upheld but not infringed, and in 27% the patents 
was revoked. Again, French patents were considerably more likely (31%) to be revoked than 
EP patents (21%). Relative to the 1990-1999 period, the more recent data suggests overall 
an increase in revocations and in decisions that upheld the patent but do not find 
infringement at the expense of the share of decisions that find infringement. 
Europe 
Mejer and van Pottelsberghe (2012) describe the patent litigation system in Europe and 
discuss its implications for business. Because they lack data on patent infringement cases, 
they rely largely on anecdotal and case evidence on the broad differences in costs, duration, 
and intensities of patent litigation in four European countries: Germany, France, the 
Netherlands and the UK. The case studies described by Mejer and van Pottelsberghe (2012) 
suggest the existence of substantial differences in litigation outcomes on the same patent 
across European jurisdictions. Harhoff (2009) focuses on the costs and benefits of the 
fragmented patent litigation system in Europe and assesses potential welfare implication of 
a unified pan-European enforcement system. Similarly to Mejer and van Pottelsberghe 
(2012), the main limitation in the analysis is the lack of data on patent cases in the various 
European jurisdictions. The absence of case-level data means that various assumptions 
about the incidence, outcomes, and costs of patent litigation in the different jurisdictions 
have to be made. Nevertheless, the results suggest that the current fragmented litigation 
system leads to costly duplication of cases across Europe, albeit not quite in the extent 
assumed by the European Commission. The case-level evidence by Mejer and van 
Pottelsberghe (2012) confirms this view. According to Harhoff (2009), a low-cost unified 
litigation system might also provide better access to enforcement for companies that 
currently cannot afford litigation in multiple jurisdictions. However, he also lists potential 
downsides of harmonization. 
In the absence of case-level data, Arundel et al. (2003) collect survey data on patent 
litigation for a small sample of less than 450 European SMEs that were granted patents at 
the USPTO or EPO between 1994 and 1997.14 The authors investigate the effect of the 
                                                        
14
 67% of firms in the sample are from Germany, the UK, and the Netherlands. 
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relative size of the infringer compared to the patent holder on the action taken against the 
infringer. They find that when small firms face infringement by a larger firm, they are less 
likely to take legal action than when faced with infringement by a firm of equal or smaller 
size despite the fact that the damage caused by infringement is reported to be much larger 
when the infringer is larger. While the analysis provides interesting insights with regard to 
the balance of powers between SMEs and larger companies when it comes to patent 
litigation, the data is limited in informing us about representative patterns of infringement 
or litigation because of selection bias in terms of responding to the survey and item-non 
response, which the authors do not take into account in their descriptive analysis. Rodwell 
et al. (2007) offer another survey-based analysis of 140 European SMEs, although the study 
faces the same sample selection problem as Arundel et al. (2003). Rodwell et al. (2007) find 
that 75% of sampled firms are affected by IP infringement (most commonly design rights, 
44%). The data reveal that about 20% of sampled companies subject to infringement 
reported not to have taken any action in response. 
To the best of our knowledge, the only study using case-level data for various European 
jurisdictions is van Zeebroeck and Graham (2011). They rely on private data on IP litigation 
collected by data from Darts-IP to provide descriptive evidence on the incidence and 
character of patent litigation in seven European countries: Belgium, France, Germany, Italy, 
Spain, the Netherlands, and the UK. They observe significant differences in the likelihood of 
reaching a final decision in patent litigation across jurisdictions, with much larger relative 
frequencies of decisions in some countries (e.g., the Netherlands) than in others (e.g., the 
UK). They also find litigation intensities to vary substantially across technological areas. 
While these studies have cast some light on litigation in Europe, they have suffered from 
various shortcomings, perhaps most importantly, the lack of comprehensive data on court 
cases across jurisdictions. The advantage of the dataset used in this study is that we observe 
additional information and that – at least for Germany and the UK – we also have data on 
cases that were settled. 
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3 Enforcement Systems 
This section describes the enforcement systems in the four countries covered by our 
analysis. We separately discuss the most important differences and commonalities across 
the different jurisdictions which inform our empirical analysis. 
3.1 Germany 
The German patent system is illustrated in the following Figure and further explained below. 
Figure 1: Overview of Patent Litigation System in Germany 
 
3.1.1 Applicable Law 
European Patents are granted on the basis of the European Patent Convention (EPC).15 The 
EPC contains the rules for the granting procedure of European patents (EP) and the validity 
                                                        
15
 English version at: http://www.epo.org/law-practice/legal-texts/html/epc/2010/d/index.html (last visited 
30.08.2013).  
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proceedings before the EPO. However, according to Art. 2 and 64 EPC, the rights conferred 
by the respective national parts of an EP and the infringement and validity proceedings 
before the national courts, are governed by the law in the respective countries in which the 
patent was validated. 
Therefore, likewise to German national (DE) patents, the rights conferred by the German 
part of a European patent and the options for challenging the validity of the patent are 
stipulated in the German Patent Code (Patentgesetz – PatG)16 and the Law on International 
Patent Treaties (Gesetz über internationale Patentübereinkommen – IntPatÜG).17 With 
utility models (Gebrauchsmuster), Germany has a second type of technical intellectual 
property right. The rights conferred by utility models and the options for challenging the 
validity of utility models are set forth in the German Utility Model Code 
(Gebrauchsmustergesetz – GebrMG).18  
The main rules for the legal procedures regarding infringement, validity and costs are set 
out in the Code for Civil Procedures (Zivilprozessordnung – ZPO), the court cost code 
(Gerichtskostengesetz – GKG) and the lawyers remuneration code (Rechtsanwalts-
vergütungsgesetz – RVG).19 
3.1.2 Competent Court for Infringement Action 
In Germany twelve regional courts, Landgerichte (LGs), are competent to hear patent and 
utility model infringement cases: Berlin, Braunschweig, Düsseldorf, Erfurt, Frankfurt, 
Hamburg, Leipzig, Magdeburg, Mannheim, Munich I, Nuremberg-Fürth and Saarbrücken.20 
Each of these LGs has one or more designated patent chambers (Kammern). A case is heard 
by a panel of three judges. In Düsseldorf, Mannheim and Munich the chambers hear 
predominantly patent-related cases.21 
Appeals against the decisions of the LGs are heard by the higher regional courts 
(Oberlandesgericht – OLG).22 There is no need for an express leave to appeal. Against the 
decisions of the higher regional courts, a second appeal can be brought before the Federal 
                                                        
16
 English translation at: http://www.wipo.int/wipolex/en/details.jsp?id=6128 (last visited 30.08.2013). 
17
 English translation at: http://www.gesetze-im-internet.de/englisch_bgb/ (last visited 22.09.2013) 
18
 English machine translation at: http://www.wipo.int/wipolex/en/details.jsp?id=10002 (last visited 
22.09.2013) 
19
 English translation partly available at: http://www.gesetze-im-internet.de/Teilliste_translations.html (last 
visited 30.08.2013). 
20
 See § 143 PatG and § 27 GebrMG and the relevant regulations of the respective federal states. 
21
 See §§ 253 ZPO seq. for the main rules governing the infringement proceedings. 
22
 See §§ 511 ZPO seq. for the main rules governing the appeal proceedings. 
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Court of Justice (Bundesgerichtshof – BGH). Leave for the second appeal can be granted by 
either the OLG or the BGH.23 
3.1.3 Options for challenging the validity of a patent 
The LGs have no jurisdiction to decide on the validity of a patent – neither in form of a 
defense against a patentee’s claims for patent infringement nor in form of a (counter-) claim 
for declaratory judgement of invalidity (this is referred to as bifurcation of infringement and 
validity proceedings). The situation is different for infringement suits on the basis of utility 
models in which the defendant is allowed to raise an invalidity defense. 24  
In both patent and utility model infringement proceedings the infringement court has the 
discretion to stay the proceedings until parallel invalidity proceedings before EPO, DPMA 
(Deutsches Patent- und Markenamt) and BPatG (Bundespatentgericht) have been 
terminated.25 
As in all contracting states of the EPC, the validity of an EP patent can be challenged by filing 
an opposition before the EPO. Only the EPO is competent for invalidating the EP with effect 
for all contracting states of the EPC. The decisions of the EPO can be appealed before the 
EPO’s board of appeals.26 The validity of a DE patent can be challenged by filing an 
opposition before the DPMA27 German Utility models can be challenged in cancellation 
proceedings (Löschungsverfahren) before the DPMA.28 The decisions of the DPMA can then 
be appealed before the Federal Patent Court.29  
Only after the deadline for filing an opposition against a DE or EP patent have lapsed and all 
pending opposition and appeal proceedings against the patent have been terminated, an 
invalidity action against an EP and DE patent can be filed before the BPatG.30 The decisions 
of the BPatG can be appealed before the BGH. Therefore, the BGH is the only court in 
Germany which has jurisdiction to decide on both infringement and validity. Within the BGH 
only the X. (Roman ten) and the Xa. senates are competent to hear patent cases.31 
                                                        
23
 See §§ 542 ZPO seq. for the main rules governing the second appeal proceedings. 
24
 See BGH, Opinion dated June 5, 1997 – X ZR 139/95, BGHZ 136, 40, 42 – Leiterplattennutzen (English 
translation not available). 
25
 See § 148 ZPO. 
26
 See Art. 99 EPC seq. 
27
 See §§ 21 and 59 PatG seq.  
28
 See § 25 GebrMG seq. 
29
 See § 73 PatG seq. 
30
 See §§ 65, 81 PatG seq. and Art. II § 2 IntPatÜG. 
31
 The Xa. senate was created to decrease the backlog of the X. senate and existed only from January 1, 2009 
until December 31, 2010. 
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3.1.4 Structure of Proceedings 
Traditionally, German law foresaw only very limited claims for disclosure of information 
and/or inspection of potentially infringing products.32 Since the implementation of the 
enforcement directive in 200833 German procedure foresees new and more efficient claims 
for inspection and production of information which can be initiated before or in parallel to 
the first instance proceedings by way of preliminary proceedings without notice to the 
defendant.34 In practice, such proceedings are still the exception. 
German infringement proceedings start with filing a complaint substantiating the alleged 
infringement at a LG. The claimant is relatively free to choose the LG for the case since he 
can choose the jurisdiction of the defendant or the jurisdiction where (part of) the potential 
act of infringement, such as an offer of the allegedly infringing embodiment, has taken 
place. 
The court then serves the complaint to the defendant. With regard to the first instance 
infringement proceedings before the LGs, practitioners talk about the Düsseldorf-, 
Mannheim- and Munich models.35 The models differ in the timing and number of oral 
hearings (one or two) and the matters dealt with during these hearings (substantial 
questions or only case management). In all "models" the proceedings are mostly written 
and governed by extensive obligations of substantiation (Substantiierungspflichten). 36 
Further, first instance proceedings are relatively quick (as also borne out by our data) since 
the parties are usually allowed to put forward only two writs each, and expert opinions are 
ordered only in exceptional cases. The first oral hearing is usually scheduled after 6-12 
months. 
Oral hearings are usually brief; they almost never exceed one day and often last for only 2-4 
hours. Hearings start with an introduction of the presiding judge who gives the court’s 
preliminary opinion based on the writs exchanged before the hearing. Afterwards the 
presiding judge leads the lawyers with specific questions regarding open issues. During the 
                                                        
32
 In principle § 142 ZPO and § 809 BGB allowed for inspections and exchange of written evidence but the 
German courts were very hesitant to apply these rules. 
33
 See Directive 2004/48/EC, available at: http://ec.europa.eu/internal_market/iprenforcement/directive/ 
index_en.htm and the German implementing law: Gesetz zur Verbesserung der Durchsetzung der Rechte des 
Geistigen Eigentums, BGB part I dated July 11, 2008, pages 1119-1211 
34
 See. § 140 c PatG and 24 c GebrMG and Kühnen (2013) recitals 304 seq. 
35
 The Munich model, known for its early hearing, rigid deadlines and the option for mediation, was introduced 
in 2009. During the time of our data collection, practices in Munich and Mannheim had been quite similar. See 
Herr and Grunewald (2012) for more discussion on the differences between the courts of Düsseldorf, 
Mannheim, and Munich. 
36
 For example, a defendant is not allowed to simply deny allegations of the claimant but has to explain why 
the allegation is wrong (especially in view of infringement) – otherwise the allegations of the claimant are 
upheld undisputed, see § 138 ZPO; for the details see Kühnen (2013) recitals 295 seq. 
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proceedings the lawyers mainly answer the questions. A decision is handed down 1-3 
months after the (second) oral hearing. Usually this decision is the final judgment. 
Nullity actions are often a reaction of the defendant to an infringement action brought 
before a LG and therefore filed a couple of months after the infringement action has been 
initiated. Invalidity decisions by the BPatG take on average 18 months after the filing of the 
invalidity action before the BPatG (see Table 3 below).Therefore, if the LG does not stay the 
infringement proceedings, the claim for injunctive relief is commonly granted at least a year 
before the question of validity is addressed. 
The LG grants the stay of a case only if it is of the opinion that the revocation action, on the 
basis of a preliminary assessment, is predominantly likely to succeed. On appeal, the OLG 
uses a more lenient standard and commonly stays the proceedings if the revocation action 
is “likely” to succeed.37 
3.1.5 Preliminary Injunction 
Preliminary proceedings for asserting claims for injunctive relief are very rare in patent cases 
and not necessary under normal circumstances due to the speed of the normal infringement 
proceedings. The decision on the amount of any damages to be paid by the infringer will be 
decided in a separate suit afterwards. 
3.1.6 Enforcement 
The decisions of the LG are enforceable against the provision of a security. The latter 
ensures that the defendant will be able to recover damages if the patent is held invalid 
and/or not infringed in the second instance. The decision in the second instance is 
enforceable without security.38 
The winning party has to start enforcement proceedings (including an injunction) on its own 
initiative. Usually the winning party writes a formal letter and submits a bank guarantee as 
security. The winning party can choose which of the claims it enforces. In most cases the 
winner chooses to enforce only the claim for rendering of accounts and waits with the 
enforcement of the injunction until the validity has been confirmed or the judgement of the 
second instance has been handed down. If the winning party enforces a first instance 
judgment and the patent is later revoked, the patentee is liable for the damages it has 
caused to the defendant.39 
                                                        
37
 For details see Kühnen (2013), recitals 1574 seq. 
38
 See sec. 704, 708, 709 and 717 (2) ZPO. 
39
 See § 717 (2) ZPO. 
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3.1.7 Costs and Fee Shifting 
In all proceedings before the German courts, the court and attorney fees are calculated 
according to a formula based on the estimated value of the dispute.40 These fees are the 
basis for the reimbursement of costs which the winner of a case can demand from the loser. 
The court fees are usually higher than in other jurisdictions and range between Euro 25 and 
Euro 91,456.41 The attorney fees do not represent the true legal costs but only a lower 
bound to which the attorney is entitled. Clients and their attorneys often agree to payment 
schemes based on an hourly rate which leads to attorney costs well above the legal fees. As 
a result, the costs are often not fully shifted to the loser.42 
Since German proceedings do not foresee extensive pre-trial disclosure of information and 
only short hearings usually without experts, proceedings are usually considerably less 
expensive than in other jurisdictions even if the same hourly rates for attorneys apply. 
Practitioners estimate the average costs to range between Euro 40,000 and Euro 100,000 
per party.43 
3.1.8 Availability of Decision/Statistics 
Whereas the number of cases before the LGs and OLGs are not published, comprehensive 
summary statistics for the BPatG and the BGH are published each year.44 
3.2 UK (England and Wales) 
The patent litigation system in the UK is illustrated in the following figure and further 
explained below. 
                                                        
40
 The value in dispute (VID) is set by the court and can range from 300 Euros to 30 Million Euros (see § 39 (1) 
Litigation cost act (GKG)). Practitioners estimate the average value in dispute to be typically between Euro 
500,000 and Euro 5 million, see Bardehle (2013, p. 12). 
41
 Depending on the outcome of the case (judgment, settlement, withdrawal, etc.), the court demands 
multiples of a “1.0 court fee” (see § 3 (2) GKG). The amount of a “1.0 court fee” depends on the value in 
dispute and ranges from Euro 25 (if the value in dispute is up to Euro 300) to Euro 91,456 (if the value in 
dispute is Euro 30 million). If the case ends with a judgment, the court requests the payment of 3.0 fees, i.e. 
Euro 4,456 * 3 = Euro 13,368 if VID = Euro 1,000,000 and up to Euro 91,456 * 3 = Euro 274,368 if VID is Euro 
30,000,000. Since German courts commonly consider each patent as a separate "case”, a suit based on several 
patents costs a multiple of the 3.0 court fees and can therefore exceed the costs of Euro 274,368.  
42
 The reimbursement of the attorney fees is also calculated on the basis of multiples of a “1.0 attorney fee” 
which in turn depends on the VID. If the court renders a judgment after an oral hearing the reimbursement is 
2.5 fees per lawyer. Therefore, on average the reimbursement per lawyer is 2.5 * Euro 4,496 = Euro 11,240 (if 
VID = 1,000,000) and up to 2.5 * Euro 91,456 Euros = Euro 228,640 (at VID = Euro 30,000,000). 
43
 See CMS (2013, p. 47) and Bardehle (2013, p. 12). 
44
 The statistics of the BGH can be accessed at: http://www.bundesgerichtshof.de/DE/BGH/Statistik/ 
statistik_node.html; the statistics for the BPatG are published in the journal Blatt für Patent-, Muster- und 
Zeichenwesen. 
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Figure 2: Overview of Patent Litigation System in England and Wales  
 
3.2.1 Applicable Law 
There is no unified legal system for the UK; England and Wales, Scotland and Northern 
Ireland have separate legal systems and courts. We focus on the enforcement system of 
England and Wales, which is by far the most important of the three jurisdictions in the 
context of patent litigation.  
As is the case in Germany, noted above in 3.1.1, the EPC system applies in the context of the 
UK. The primary piece of UK legislation is the Patents Act 1977. 45 The actual processes of 
litigation at the courts in England and Wales are guided by the Civil Procedure Rules (CPR).46 
                                                        
45
 available at http://www.ipo.gov.uk/patentsact1977.pdf (see 25.09.2013). 
46
 http://www.justice.gov.uk/courts/procedure-rules/civil (last visited 23.09.2013). 
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3.2.2 Competent Court for Infringement Action 
There are two courts of relevance to our analysis, the PCC, which deals with low-value 
claims, and the PHC, which is a specialist court of the Chancery Division of the High Court of 
Justice of England and Wales. In principle, the PCC hears cases of lower value and 
complexity, such as disputes involving SMEs. Nonetheless, in practice the overwhelming 
majority of patent cases during the period 2000-2008 were heard by the PHC.47 At both the 
PCC and the PHC, each case is tried by a single judge who possesses IP-specific expertise. 
Appeals are made from the PHC to the Court of Appeal (CA). Leave to appeal must be 
granted by the PHC or by the CA itself. The appeal is decided by a three-person panel at the 
Court of Appeal, which is generally not entirely composed of IP specialists (although it 
usually contains at least one IP specialist). 
The decision of the CA can be challenged at the Supreme Court (formerly the House of 
Lords). Once again, leave must be given for appeal to the Supreme Court (SC), either by the 
CA or, if the CA refuses permission, the SC itself. Moreover, the case must be of significant 
legal or constitutional importance in order for permission to be granted.48 
3.2.3 Options for challenging the validity of a patent 
As noted above in 3.1.3, the validity of an EP can be challenged by filing an opposition 
before the EPO. There are no opposition proceedings against UK patents before the IPO. 
In England and Wales there is a combined system of filing infringement and invalidity claims 
to the same court. This means that the PCC and the PHC have jurisdiction to determine both 
infringement and the validity of a UK patent, including the UK part of a European patent. 
The jurisdiction for validity is independent of the question whether the deadlines for 
opposition against an EP patent have not lapsed and/or opposition proceedings are 
pending. However, the courts can stay the proceedings until the EPO has decided about an 
opposition. In the past, the PHC rarely granted a stay pending EPO proceedings, but a recent 
decision of the UK Supreme Court may have the effect of changing this policy in favor of 
granting a stay in such circumstances.49 Decisions on validity can be appealed to the Court of 
Appeal and Supreme Court, as noted above in 3.2.2. 
                                                        
47
 See Helmers and McDonagh (2013a), Table 1 and Table 5. 
48
 According to the Judicial and Court Statistics 2008, the number of IP related cases heard by the House of 
Lords/Supreme Court is typically negligible – there were none in 2006, there was only 1 out of 45 total cases 
heard in 2007, and only 1 out of 74 total cases heard in 2008 (Judicial and Court Statistics 2008).  
49
 Virgin Atlantic Airways Ltd v Zodiac Seats UK Ltd (formerly known as Contour Aerospace Ltd) [2013] UKSC 46 
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3.2.4 Structure of Proceedings 
Every claim begins with a claim form in accordance with CPR part 7.2, which must be served 
within four months of issue, or six months if service is out of the jurisdictions under CPR part 
7.5.50 After the claim form is served, an acknowledgement of service, and then the defense, 
must be filed. The claimant then must apply for a case management conference (CMC) 
within 14 days of the date when all defendants who intend to file and serve a defense have 
done so.51 At the CMC, directions are given for the further conduct of the action, including 
disclosure of information or experiments, and the hearing date for trial is usually set. 
The courts in England and Wales provide a large number of options for the obtaining of 
evidence.52 In appropriate cases, the court may order disclosure of internal documents, the 
preparation of a product or process description (with the required level of detail specified), 
inspection of factory processes, provision of samples or ingredients and experiments (to be 
repeated in the presence of the other party). Once documents have been read out or 
referred to in open court they can then normally be used in proceedings elsewhere.53 
Cases filed before the PHC can take around a year to make it to full trial. If proceedings are 
expedited, however, cases can sometimes reach trial within six months. Practitioners 
estimate that 12-18 months is the average wait for a large case to reach full trial.54 Our data 
suggests that cases take on average slightly less than a year to reach a decision in first 
instance.  
At trial both parties present their full case, relying on evidence by witnesses and experts 
who are cross-examined by both parties, and thehe trial concludes with closing statements 
by counsel. Practitioners estimate that PHC trials can last between two days and several 
weeks, depending on the complexity of the case and the amount of witnesses/experts cross-
examined.55 Following the conclusion of a full hearing, a first instance judgment will usually 
be handed down within 2-12 weeks. 
If a claimant in the case believes that there is no realistic prospect of the defense 
succeeding, an application for summary judgment can be made. A hearing for summary 
judgment can take place once the defense has been filed. Nevertheless, due to the 
                                                        
50
 Particulars of claim, which set out the claimant’s case in more detail, must be served within 14 days of 
service of the claim form (CPR 7.4). 
51
 See CPR part 63, Practice Direction 5.3. 
52
 See CPR Part 63, Practice Direction 6. 
53
 See Hogan Lovells (2013). 
54
 See CMS (2013), p. 96; Freshfields (2011), p. 6. 
55
 See CMS (2013), p. 96; Hogan Lovells (2013), part “UK”. 
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complexities involved in patent claims concerning the issues of validity and infringement, 
summary judgments are said to be rare,56 a finding which is also supported by our data. 
The first trial deals only with establishing liability. If the claimant is successful, separate 
proceedings start to determine the amount of financial compensation. According to 
practitioners these hearings are rarely pursued because cases generally settle once liability 
is determined and an injunction has been handed down.57 
3.2.5 Preliminary Injunction 
English law permits a patentee or an exclusive licensee to apply for an interim injunction to 
restrain the defendant from carrying out the allegedly infringing act for the period until trial. 
A threat of infringement can be a sufficient basis for an application which must be made 
promptly. Where justified by the circumstances (for example, urgency or secrecy), an 
interim injunction can be applied for without notice to the other side. 
3.2.6 Enforcement 
Following the conclusion of the judgment on the merits of the validity/infringement issues a 
separate hearing takes place where the consequences of the judgment are discussed. 
Various factors are taken into account in order to find the correct enforcement method, 
including the assets belonging to the infringing company, and its geographical location. 
Usually the court grants at least an injunction and orders the defendant to render accounts 
both without asking the plaintiff to provide a security. 
3.2.7 Costs and fee shifting 
Practitioners estimate the costs of a case which reaches trial to be at £1.5 million for each 
side. 58  These estimates are supported by the research undertaken by Helmers and 
McDonagh (2013b) which show costs often ranging between £1million and £6million 
(encompassing the costs from both sides) for cases initiated during 2000-2008.59 The main 
reasons for the existence of high costs are the disclosure requirement, the length of trial, 
the requirements for the carrying out of experiments and the cross-examination of expert 
witnesses.  
The loser pays costs system applies in this context - the company which loses must pay not 
only its own costs, but also the costs of the other side. However, it is also important to note 
that such costs are allocated via an issue-based approach; depending on who lost which 
                                                        
56
 See Freshfields (2011), p. 10. 
57
 See Freshfields (2011), p. 2. 
58
 See Freshfields (2011), p. 8. 
59
 See Helmers and McDonagh (2013b), p. 384.  
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issue in the case, and taking into account how much court time the issue took to resolve, the 
court allocates the costs to each side on a proportionate basis.60 
3.3 France 
The patent litigation system in France is illustrated in the following Figure and further explained 
below. 
3.3.1 Applicable Law 
As for the UK and Germany, the European Patent Convention (EPC) applies to EP patents 
validated in France.61 The rights conferred by the French part of a European patent and the 
options for challenging the validity of the patent are manifested in the French Intellectual 
Property Code (code de la propriété intellectuelle - CPI).62 The procedural rules are set forth 
in the French Code of Civil Procedure (code de la procédure civile - CPC)63 and the Judicial 
Organisational Code (Code de l'organisation judiciaire – COJ).64 
                                                        
60
 For more discussion see Helmers and McDonagh (2013b), p. 387-392. 
61
 English version available at: http://www.epo.org/law-practice/legal-texts/html/epc/2010/d/index.html (last 
visited 30.08.2013).  
62
 English translation available at: http://www.wipo.int/wipolex/en/details.jsp?id=5563 (last visited 
06.09.2013). 
63
 English translation at: http://www.legifrance.gouv.fr/Traductions/en-English/Legifrance-translations (last 
visited 06.09.2013). 
64
 French version at: http://legifrance.gouv.fr/affichCode.do?cidTexte=LEGITEXT000006071164 (last visited 
22.09.2013) (English Translation not available). 
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Figure 3: Overview of Patent Litigation System in France 
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65
 See Ladas and Parry (2002) and Véron (2002), p. 388. 
66
 See Art. R 211-1 COJ. 
67
 See Art. L615-17 CPI and D211-6 COJ (decree dated 9th October 2009). 
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only competent CdA is now the CdA in Paris. The decisions of a CdA can be appealed to the 
Supreme Court (Court de Cassation - CdC).68 
3.3.3 Options for challenging the validity of a patent 
As explained with regard to Germany above (3.1.3) European patents can be challenged 
before the EPO. There is no opposition procedure to challenge French patents at INPI.69 
In France, like the UK, there is no specialized court for revocation actions. If infringement 
proceedings are already pending, the invalidity can be raised as counterclaim or defense for 
revocation.70 However, the validity of FR patents and the French part of EP patent can also 
be challenged in an isolated revocation action.71 According to practitioners, isolated action 
for revocation and the defense for revocation are very rare. In most cases (>90%) the 
validity issues are raised as a counterclaim for revocation.72 The revocation of a patent has 
general effect (erga omnes).73 The courts have wide discretion to stay proceedings during a 
pending opposition at the EPO but do so only if they find that the likelihood of success of 
the opposition is high.74 
3.3.4 Structure of Proceedings 
Infringement proceedings are in the large majority of cases preceded by a request for search 
and seizure of evidence (saisie contrefaçon).75 The patentee can file such a request before 
the President of the Tribunal de Grande Instance of the location where the infringement has 
taken place to obtain the authorization to carry out a search and seizure. The President is 
not entitled to refuse the authorization if a patent is at issue which is in force. The only 
power of the President is to determine the extent of the search and seizure.76 
The search and seizure is carried out by a bailiff (huissier de justice) chosen by the plaintiff. 
On the day of the search and seizure he may arrive with a person skilled in the art,77 a police 
                                                        
68
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officer, or any person whose technical skills can be useful. These persons can enter into the 
premises of the alleged infringer, examine the allegedly infringing product, device or 
process, describe it, be supplied with a few examples thereof, and make copies of technical, 
accounting and financial documents relating to the infringement, even if they are 
confidential.78 
Within two weeks after the search and seizure has been carried out the plaintiff has to serve 
a writ of summons on the alleged infringer. If he fails to do so, the saisie will be declared 
invalid (the description part of the protocol remaining valid) and the patentee may be held 
liable by the alleged infringer for any damage or cost caused by the seizure.79 
The writ of summons is the act, which starts the proceedings, and includes the plaintiff's 
claims, which is generally formulated relatively summarily. Once the writ of summons has 
been served, the plaintiff has to register it in the register of pending cases at the court office 
(placer l'affaire).80 The procedure before the TGI is largely in writing. The statute sets no 
limits for the number of writs to be exchanged between the parties. According to 
practitioners, three or four written pleadings are usually communicated.81 
The hearing is conducted by a panel of three judges. During the oral hearing witnesses are 
questioned only exceptionally: their testimonies are usually recorded in writing, then 
submitted to the court as exhibits. Since the exhibits are introduced in the proceedings only 
shortly before the hearing, the judges often are not able to study the patent at issue. 
Therefore, the judges usually do not present a preliminary opinion and do not lead the 
lawyers with questions.82 Therefore, the lawyers usually plead in order to supply the Court 
with a first clarification on the case. Usually, the pleadings take between one and three 
hours. Only in exceptional cases the hearings take more than one day.83 
A few weeks after the hearing, the court hands down a decision. In rare cases, the decision 
is an order for an expert report regarding a fact related to infringement and disputed by the 
defendant. In most cases it is the final decision that is handed down.84 Practitioners 
estimate that first instance proceedings usually take between 18 and 22 months from filing 
the writ of summons to the decision.85 
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3.3.5 Preliminary Injunction 
After a claim for infringement has been submitted to the court, a plaintiff can request the 
President of the court, who adjudicates in preliminary proceedings, to order a preliminary 
injunction until the judgment is handed down. 86  According to practitioners, such 
interlocutory injunctions are very rare.87 An interim injunction can also be obtained before 
filing an action on the merits following which the claimant has 20 working days or 31 
calendar days to file such an action.88  
3.3.6 Enforcement 
In France the provisional enforcement is not a right; it is granted only on the request of a 
party and if the circumstances justify it. The provision of a security is rarely required.89 
3.3.7 Costs and fee shifting 
In French proceedings the involvement of the court is entirely free.90 Most of the time, the 
attorney fees are calculated according to an hourly rate agreed with the client. The usual costs 
of the proceedings are estimated to range between Euro 50,000 and Euro 200,000.91  
In principle, the French system shifts the costs to the loser.92 However, in practice the fees are 
shifted only to a very limited extend. For example, practitioners estimate that the sum of the 
granted litigation costs are on average between Euro 200 and Euro 300 and the lawyer’s fee 
granted are on average about Euro 3,000.93  
3.4 The Netherlands 
Figure 4 shows the Dutch patent litigation system schematically. 
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Figure 4: Overview of Patent Litigation System in the Netherlands 
 
3.4.1 Applicable law 
As for Germany, France and the UK, the European Patent Convention applies to EP patents 
validated in the Netherlands.94 The rights conferred by the national part of a European 
patent and the options for challenging the validity of the patent in the Netherlands are laid 
out in the Dutch Patent Act of 1995 (Rijkswet van 15 december 1994, houdende regels met 
betrekking tot octrooien – DPA).95 The procedural rules are set forth in the Dutch Code of 
Civil Procedure (Wetboek van Burgerlijke Rechtsvordering - Rv).96 
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3.4.2 Competent Courts for Infringement Action 
Since 1987 the Netherlands have a highly centralized system of patent enforcement.97 All 
patent matters must be brought before the courts in The Hague (s’Gravenhage) which have 
exclusive jurisdiction.98 First instance actions must be filed at the patent chamber of the 
district court (Rechtbank) and an appeal may be taken to the patent chamber of the court of 
appeal (Gerechtshof). Judges in both courts receive technical as well as legal education, and 
past Dutch patent office employees may serve in the patent chamber of the courts. Appeal 
decisions may be subject to final judgment at the Supreme Court (Hoge Raad).  
3.4.3 Options to challenge the validity of a patent 
As explained with regard to Germany above (3.1.3) European patents can be challenged 
before the EPO. There is no opposition procedure for Dutch patents. 
Infringement and validity are dealt with by the same court, either in the same proceedings 
(when invalidity is raised as a means of defense), in separate but simultaneous proceedings 
(an invalidity action by way of a counterclaim), or in separate revocation proceedings.99 The 
validity of a Dutch patent can always be challenged.100 
If the validity of the Dutch part of a European patent is challenged while opposition 
proceedings are pending, the validity proceedings are usually stayed. Infringement 
proceedings are normally not stayed while pending opposition proceeding.101 
3.4.4 Structure of proceedings 
Before 2007 neither a French type of saisie nor a UK type of disclosure was available.102 
Since the enforcement directive was implemented in 2007, the Dutch system has a new 
procedure for securing evidence.103 In these proceedings, the patentee files a written 
request with the Preliminary Relief Judge. These proceedings are usually conducted ex 
parte.104 
Actions on the merits may be initiated without the involvement of the court. A writ of summons 
must be served on the defendant by a bailiff. Once the writ is served, the proceedings are 
considered to be pending. The court may be notified of the action at a later date. The writ is the 
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written statement of the plaintiff’s case and must contain a full description of the case 
(including the defendant’s arguments if known to the plaintiff) and indicate the evidence that 
the plaintiff will rely upon. The defendant’s statement must contain a written statement of its 
case and indicate all the evidence it intends to rely on. The statement of defense may also 
contain a counterclaim in the action.105 
In accelerated proceedings on the merits the claimant may then submit a statement of defense 
in the counterclaim. In such accelerated proceedings, no further statement will be filed by 
parties. In regular proceedings on the merits the court may give an interim order to the parties 
to appear in court to provide additional information, to plead their case (interactively) before 
the court, to investigate the possibility of a settlement or for case management purposes. In 
patent litigation it is customary to provide the court with an oral explanation of the 
arguments.106 The courts may appoint an independent expert to give an opinion on technical 
matters and file a report in court. According to practitioners it is rare that the courts rely on 
independent experts.107 
Practitioners estimate that accelerated proceedings on the merits lead to a decision within 
10 to 11 months while the normal proceedings on the merits are decided within 16 to 20 
months.108 
A special aspect of the Dutch litigation system is that during the mid-1990s, Dutch judges 
began imposing cross-border injunctions.109 Subsequently, it became common practice for 
Dutch patent judges to forbid infringement on litigated patents both in the Netherlands and 
abroad. Given the existence of single, fast, and affordable legal actions in the Netherlands, 
patent holders began using the Dutch system to stop infringement of their patents all over 
Europe. However, the availability of cross-border injunctions was considerably limited by 
decision GaT/LuK of the European Court of Justice in 2006. Since 2006 cross-border 
injunctions have only been available in preliminary relief proceedings. 
3.4.5 Preliminary Injunction 
The Dutch litigation system offers two types of preliminary proceedings. First, the Dutch 
system offers preliminary relief proceedings, called the KortGeding, for urgent cases. The 
plaintiff serves a writ of summons for the defendant to appear at a certain date before the 
President of the court. The writ of summons itself is concentrated: it contains the claim of 
the claimant and a brief indication of the basis of the claims. During the hearings there is an 
oral explanation from the claimant where the defendant can defend himself. The presiding 
judge gives his written decision with the grounds therefore within one or two weeks. Appeal 
                                                        
105
 See CMS (2013), p. 61. 
106
 See CMS (2013), p. 61. 
107
 See CMS (2013), p. 62. 
108
 See Swens (2011), pp. 8 and 9. 
109
 See Bertrams (1995), p. 618 seq. 
29 
 
and final appeal are possible.110 Therefore, a patentee may obtain a preliminary injunction 
within 2 to 3 months after filing a case. In these proceedings the Dutch courts still grant 
cross-border injunctions.111 
Second, since the implementation of the Enforcement Directive in 2007, the court might 
grant ex parte injunctions if there is no reasonable doubt of infringement and the patentee 
shows an urgent interests. These ex parte injunctions are exceptional but may be awarded 
especially in case of repeated infringement or against a distributor when infringement 
against the manufacturer has already been decided. However, no cross border injunction is 
available in these proceedings.112 
3.4.6 Enforcement 
Typically Dutch courts grant an injunction if they find infringement. In addition, the infringer 
usually also has to pay a fine to the patentee for every day he acts in contempt of the 
injunction, or every infringing product manufactured or used in contempt of that 
injunction.113  
In principle, an appeal against a first instance decision has suspensory effect. However, the 
plaintiff can request to declare the decision provisionally enforceable and the courts usually 
grant such a request.114 If the plaintiff enforces a decision in kort geding and subsequently 
gets the case dismissed in proceedings on the merits is responsible for any damages.115 
3.4.7 Costs and fee shifting 
Patent Litigation in the Netherlands is estimated to cost on average between Euro 60,000 
and Euro 200,000.116 In principle, the Netherlands shift the cost to the loser. Before the 
enforcement directive was implemented in 2007, the courts had usually shifted only a small 
amount of the fees.117 However, since then full costs may be shifted.118  
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4 Main Differences between the Enforcement Systems 
This section highlights briefly some of the differences that exist between the jurisdictions. 
As noted below, there are both substantive and procedural differences between the 
systems, something which must be taken into account when undertaking comparative 
analysis. 
4.1 Bifurcation 
The first main difference between the four legal systems is that Germany uses a bifurcated 
system. This is not present in any of the other three legal systems covered by our analysis. 
Moreover, the existence of bifurcation is a significant and somewhat controversial issue, 
particularly since the proposed unified patent system also allows for bifurcation. Criticism of 
the bifurcated system is based on the fact that due to the existence of the bifurcated system 
it is possible for a regional court in Germany to grant an injunction against a potential 
infringer of a patent which is later found to be invalid by the EPO or the Federal Patent 
Court.119  
Another potential issue is that regional courts, which decide on infringement, and the 
Federal Patent Court that decides on validity construct claims independently of each other. 
This might lead to inconsistent claim constructions in the infringement and revocation 
procedures. This is often referred to as the Angora cat problem where patent claims are 
interpreted as broadly as possible in infringement procedures (a fluffy, blow-dried cat) and 
as narrowly as possible in revocation proceedings (a wet, rolled-up cat). This creates the 
problem that an infringement court might issue an injunction against a defendant on the 
basis of a broad claim construction which would inevitably lead to the invalidation in view of 
a certain piece of prior art.120 A the Federal Patent court, in contrast, the patentee uses the 
narrow interpretation, which leads to the patent being upheld. This situation is illustrated in 
Figure 5. 
  
                                                        
119
 For more discussion and empirical evidence see Cremers et al. (2013). 
120
 A patent claim must be novel over the whole breadth of the scope of protection. 
31 
 
 
Figure 5: Claim construction 
 
Furthermore, there could be fewer counterclaims for revocation in the bifurcated system as 
costs involved in engaging in an additional, separate court action may be prohibitive 
especially for smaller, resource-constrained companies. 
On the other hand, exclusive jurisdiction on patent validity offers the advantage of 
specialization. The Federal Patent Court charged with validity cases can train and deploy 
technical judges and accumulate experience specifically in the assessment of patent validity, 
facilitating coherent and well-founded claim construction and therefore increase legal 
certainty regarding the validity of patents. Since separate patent revocation proceedings 
increase the costs and risks for the alleged infringer, the separation of infringement and 
revocation procedures may lead alleged infringers to refrain from filing a revocation action if 
they have relatively low chances of success. Moreover, the strong presumption of validity, 
which puts considerable faith in the examination of the patent offices, could allow for a fast 
assessment of infringement claims, because validity does not need to be assessed 
simultaneously. 
4.2 Number of Competent Courts 
Another major difference between the legal systems is that in Germany several regional 
courts are competent to hear patent cases; by contrast the UK, France (since 2009) and the 
Netherlands all make use of centralized systems for patent litigation.  
This means that claimants in Germany can usually choose among several regional courts 
where to file an infringement claim, whereas in the UK, depending on the size and value of 
the claim, the filing will be either at the PCC or the PHC (both are located in London); in 
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France, since 2009 patent cases must be taken at the TGI in Paris; in the Netherlands, first 
instance actions must be filed at the patent chamber of the district court. 
4.3 Duration of the Proceedings 
Regarding time limits, in the UK first instance cases filed before the PHC often take 12 
months to reach full trial, but urgent cases can sometimes be heard within 6 months. The 
first instance judgment will usually be handed down within 2-12 weeks. Therefore there is a 
typical overall length of around 12-14 months from filing to judgment. Similarly, in France 
first instance actions take on average about 18-24 months from claim to judgment. 
In Germany, proceedings before the LG tend to be relatively speedy with the (first) oral 
hearing scheduled after 6-12 months, and judgment 1-3 months after the (second) oral 
hearing. Invalidity decisions by the BPatG take usually at least 18 months after the filing of 
the invalidity suit before the BPatG. In this respect it is important to recall that invalidity 
actions are usually reactive actions and therefore filed after the infringement action has 
been initiated. Similarly, in the Netherlands it is said that proceedings are comparatively 
speedy. 
These differences in the lag between the filing of a claim and the corresponding judgment 
provide incentives for the strategic filing of patent actions in faster jurisdictions. Patentees 
might want to try to obtain a favorable judgment in Germany and use an enforceable 
injunction to obtain a favorable settlement in other jurisdictions. 
4.4 Preliminary Injunctions 
With respect to preliminary proceedings, in Germany such proceedings are very rare in 
patent cases due to the speed of the normal infringement proceedings. Instead, injunctions 
can be granted by the LG based exclusively on an assessment of the infringement claims. As 
noted above with regard to bifurcation, if the LG does not stay the infringement 
proceedings, the claim for injunctive relief is granted at least a year before the question of 
validity is even considered by the Federal Patent Court. 
In France, preliminary proceedings – the saisie-contrefaçon -- are commonly used to initiate 
infringement actions. As noted above, the court in France may order the seizure of the 
defendant’s goods within a few weeks of the action. Nevertheless, preliminary injunctions 
tend to be rare in France. This is also the case in the system of England and Wales, where 
preliminary injunctions are relatively uncommon. This might be partly explained by the 
practice of “clearing the way”. As discussed earlier, in the UK it is expected that a 
competitor should attempt to “clear the way” before e.g. releasing a product which could 
infringe another company’s patent.121 If a competitor does not do this, it is more likely that 
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the PHC will grant a preliminary injunction preventing the sale of the potentially infringing 
product upon the commencement of infringement proceedings. In the Netherlands, the Kort 
Geding, a system of preliminary relief proceedings, comes into play. A preliminary injunction 
to halt infringing activities may be obtained within two weeks after filing a case. It also used 
to be commonplace in the Netherlands for a cross-border injunction to be granted with 
respect to infringement actions. 
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5 Data collection 
The data were collected from court records in the four countries. There were some 
important differences in the way the data were collected in the different jurisdictions – 
these methods are described below. Apart from access to court records, the main challenge 
in the data collection was to achieve comparability while still accounting for the legal 
differences across jurisdictions. To this end, we designed a common template that accounts 
for the differences in the legal regimes which ensures the information extracted from court 
records can be compared across jurisdictions. We collect data for cases filed during the 
period 2000-2008. This captures relatively recent cases and avoids having a large number of 
pending cases in the dataset (if we included cases filed after 2008, most of them would have 
still been pending in first or second instance during the time period the data was collected).  
5.1 Germany 
Due to the existence of the bifurcated system, the data on infringement and invalidity 
disputes had to be collected separately.  
With regard to data collection of infringement cases, there is a fundamental challenge: 
regional courts do not publish any court records and they do not systematically list cases 
and types of cases heard before the chambers. Moreover, the ability to obtain access to 
court records hinges crucially on the approval of the judge that presides over a given 
regional court.  
To cover the largest number of court cases possible while observing our resource 
constraints, we chose the three most prevalent courts of the 12 existing regional patent 
courts in Germany: Düsseldorf, Mannheim, and Munich.122 The identification of the relevant 
patent cases – including both invention patents and utility models (Gebrauchsmuster) – 
among other IP related cases such as trademark or design cases, inventor employee issues 
and pure licensing issues, was done by screening all cover pages of written case files in 
Mannheim and Düsseldorf: In Munich, the identification of patent cases was done based on 
handwritten lists created by judges. The relevant information on the cases is stored in paper 
format in the court dockets. That means all case-related information had to be collected 
manually for each individual case by physically accessing the court dockets at each regional 
court. These obstacles made the collection of data on court cases in Germany very resource-
intensive. 
We started the data collection in Mannheim in spring 2010. We proceeded with Munich in 
December 2010 and Düsseldorf in December 2011. On average, seven trainee attorneys 
were hired in each court location to collect the data from court files and to digitize the 
information. The trainee attorneys were trained in general law and in most cases had 
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already obtained their law degree (2. Staatsexamen). They were trained for the data 
collection to become familiar with the subject of patent cases, court records as well as with 
the data template. 
The information extracted from the case files is organized into three main categories: 
information on the proceedings, the litigating parties, and the patent(s) involved. The first 
category covers a brief description of the stages of the infringement case. It includes the 
dates of filing, the oral hearing, and the ruling. Almost all case files reported the outcomes 
(which includes settlement), including the outcomes of any first and second appeal. Cost 
figures, when available, were also collected, with paid damages added to the costs. The 
second category covers the names and addresses of the litigating parties as well as of their 
legal representatives involved in the trials. We also collected the patent numbers of all 
patents involved in a dispute. Our data on patent infringement actions before the German 
courts in Mannheim, Düsseldorf, and Munich cover around 80% of all patent related cases 
during the period 2000-2008.123  
We also have information on revocation proceedings before the BPatG and its appeal court, 
the BGH. Both courts publish all decisions on validity since 2000 on their websites. Apart 
from these judgments, we also obtained information on withdrawn revocation actions from 
the German Patent and Trademark Office (DPMA). The available data for invalidity suits are 
complete for the period from 2000-2008.  
German procedural law requires claimants of infringement disputes to combine all patents 
involved in the alleged infringement in one action.124 However, for practical handling, the 
infringement courts may split up an action into several cases, one for each patent 
involved.125 In addition, requests for preliminary injunctions and the calculation of damages 
are mostly decided in antecedent or, respectively, subsequent proceedings.  
To facilitate a cross-jurisdictional comparison of the number of legal patent disputes, we 
distinguish case numbers in the following way. Firstly, since in the UK we could only access 
cases that were scheduled for a hearing, we try to level the playing field by generating a 
subsample of German cases that excludes very early settlements. 126  Secondly, we 
distinguish between cases that involve both invention patents and utility models and cases 
that involve only invention patents. Thirdly, we also consolidate cases if there is reason to 
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assume that several case numbers are in fact part of the same legal patent dispute. We 
combine cases that were separated at the patent-level by identifying all parallel proceedings 
in which exactly the same parties (claimants and defendants) litigate on basis of different 
patents at the same time. Temporally separated proceedings that belong to the same case 
are combined by identifying consecutive proceedings in which the same parties (claimants 
and defendants) litigate on basis of the same patent. A revocation action, which is filed at 
the BPatG, represents another separate case even when the case represents a reaction to 
the alleged infringement of a patent. Revocation actions rarely involve more than one 
patent. This means that if an infringement case involves several patents, not only the 
infringement case possibly unfolds into several cases, but also a separate invalidity case is 
filed for each patent. Thus, we also combine infringement proceedings with their 
corresponding revocation proceedings.127See Section 5.9 below for more details. 
5.2 UK 
We collected data on all court cases filed between 2000 and 2008 at the PHC, the Court of 
Appeal and the House of Lords/Supreme Court which involved a patent.128 We exclude all 
cases that represent an appeal to an administrative decision taken by the UK Intellectual 
Property Office (UK IPO).129 
In contrast to Germany, court records in patent cases are generally, albeit selectively, 
published. We therefore collected the data on court cases at the PHC from a range of online 
sources. Our starting point was the Patents Court Diary which, in principle, lists all cases 
which are scheduled for a hearing or an application including, for example, a case 
management conference.130 This means the Diary contains all cases which have been 
scheduled for a hearing. 
It is important to emphasize that any case which settles after filing, but before it is 
scheduled for a hearing,131 including a CMC, would not appear on the Diary, and therefore 
does not form part of our dataset. Nevertheless, cases which settle after they have been 
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scheduled for a hearing, regardless of whether the hearing eventually took place, are listed, 
and therefore form part of our study.  
The Diary typically provides basic information on court cases, including the case number, the 
names of claimants and defendants (usually only the first claimant and defendant), their 
legal representatives, the date the hearing was fixed, as well as the hearing dates and the 
duration of the hearing. In a number of cases the Diary also notes additional information, 
such as whether a case was discontinued because of a settlement or stay. We use the 
information from the Diary to search for court records on the website of the British and Irish 
Legal Information Institute,132 the case database of Lexis Nexis,133 as well as Thomson 
Reuters’s Westlaw database.134 Nonetheless, these sources did not offer any records for a 
number of cases (presumably mostly those settled at an early stage). For these cases we 
searched additional sources, such as media websites, blogs or the websites of legal 
representatives for information. 
The most basic information that we collected for all cases includes the names of all litigating 
parties, their country of residence (the country in which a firm is registered), the type of 
litigating party (e.g. company, individual, etc.), the year the claim form was served, and the 
type of IP right in dispute. Additional detailed information on the case was collected for all 
court cases that involved a patent. The information was collected and input into the 
standardized template. We recorded information on the proceedings/decision type, 
litigating parties, the IP right in dispute, the claims made in the case, the relief applied for, 
the outcome/content of the judgment, and any information on the value, costs, and 
potential damages associated with the case. We also include information on related cases 
taken within the England and Wales jurisdiction, as well as in jurisdictions abroad, if such 
cases were mentioned in the available court records. The inclusion of information on the 
mentioned cases taken abroad facilitated the identification of parallel disputes, as explained 
below in more detail. 
While our datasets represent the most comprehensive database gathered so far on the 
subject of patent litigation in the UK,135 at least three caveats are in order. Firstly, relying on 
the court diary means that we only observe cases that not only have been filed to the court, 
but which were also allowed to proceed at least to the case management stage. There is no 
information available on the number of cases which are dropped between the serving of the 
claim form and the case appearing on the diary. The number of cases within our dataset is 
comparable with the official UK Ministry of Justice (MoJ) statistics on case numbers at the 
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 http://www.bailii.org (last visited 23.09.2013) 
133
 http://www.lexisnexis.co.uk. (last visited 23.09.2013) 
134
 http://www.westlaw.co.uk. (last visited 23.09.2013). 
135
 The data used by Moss et al. (2010) only contain court cases between January 2008 and August 2009 heard 
by the Patents County Court, the Patents Court, the Court of Appeal, and the House of Lords. 
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PHC, once the cases which do not form part of our study, i.e. appeals from the IPO and the 
non-patent PHC cases, are removed.136 
Secondly, since we had to assemble the information with regard to each court case, often 
relying on different sources, the available court records are in many cases incomplete. For 
example, while we may have the judgment of the PHC, we may not have records for all 
preceding applications. A particular concern relates to the patent numbers of litigated 
patents because even when a case is decided through judgment, the published judgment 
may not identify the disputed patents. This means that we only have patent numbers for 
165 out of the 256 patent cases between 2000 and 2008. 
Thirdly, with regard to the counting of UK cases, for the purpose of clarity it is important to 
note that where a number of separately filed cases involving the same parties were joined 
and heard together we considered these cases to be “one case.”  
5.3 France 
The French dataset contains patent cases at the Court of Paris in first and second instance 
(Tribunal de Grande Instance – TGI and Cour d’Appel). While Paris has exclusive jurisdiction 
over patent disputes in France since 2009, ten courts were sharing jurisdiction over patent 
disputes during the period 2000-2008 covered by our data. According to Véron (2002), the 
TGI in Paris accounted historically for around 60% of all patent cases in the country.137  
Our data for France originate from a private company, Darts-IP, which specializes in IP case 
law. The company collects data on IP disputes directly from records published by the courts. 
Darts-IP was helpful mainly for two reasons: first, the TGI is not specialized in patent cases 
and court registers do not record patent cases in a specific way that would allow filtering 
them from the huge collections of all cases filed at the court. Darts-IP collects decisions from 
all cases and manually identifies the nature of the main action, allowing us to filter patent 
cases. Similar to the UK, information can be obtained from published court records because 
in the French litigation system, as soon as an action is filed at a given TGI, the court quickly 
issues an official document called an Ordonnance de mise en état, which summarizes the 
claims filed by the claimant and sets the calendar for the case. These documents reveal 
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 For the PHC in 2007 the MoJ lists 55 actions and for 2008 it lists 61 actions. See Ministry of Justice, Judicial 
and Court Statistics 2007 (The Stationery Office, September 2008) and Judicial and Court Statistics 2008 (The 
Stationery Office, September 2009); accessible at http://www.official-
documents.gov.uk/document/cm76/7697/7697.pdf and http://www.official-
documents.gov.uk/document/cm74/7467/7467.pdf. Recently we examined the paper PHC case files at the 
court. The physial PHC files are mixed in with regular Chancery Division files, which makes the case-counting 
extremely challenging and time-consuming. Nevertheless, counting records for cases filed at the PHC in 2007 
revealed that there were an additional 7 cases filed which did not appear in the diary or elsewhere in the 
online records available to us. Nonetheless, we judge that there is unlikely to be a substantial number of 
missing (early settled) cases filed in 2007 for which we lack information. 
137
 Véron (2002, p. 388) notes that the distribution of patent cases among the ten courts was highly skewed as 
seven out of the ten courts dealt with less than 15 cases per year. 
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most of the features of the case (names of the parties, patent numbers, filing dates, etc.). 
Darts-IP obtains data also from the French patent office (INPI) and Véron & Associés (a 
prominent law firm) that also collect data on patent cases at the Paris court. Secondly, 
Darts-IP analyzes court records and manually retrieves the information on the litigating 
parties, patent numbers, filing and judgment dates, and some other features of the case.  
We complement the Darts-IP data with additional variables that we extracted manually 
including the type of first action, outcomes, appeals, etc. As in the case of the UK, we then 
exclude appeals to administrative decisions of the INPI (the Court of Paris also has 
jurisdiction as an appellate level to decisions of the French patent office, but this is not the 
focus of our dataset). Once the analysis at the individual decision level was completed, we 
grouped all court records into unique cases. This grouping is done in several steps: (1) Darts-
IP links every decision to its antecedent, forming a chain of decisions relating to the same 
case, (2) we use case references attached to each decision to identify further decisions 
belonging to the same case that were not linked by Darts-IP, (3) we look for all dockets that 
have at least 2 parties and 1 patent family in common and manually check whether these 
belong to the same action, in which case we merge them into a single case record. This 
aggregation is presumably the main reason why the figures presented in Table 2 below 
differ significantly from the case counts in Véron (2010) for the TGI Paris for the same time 
period. Case-level variables are then computed or aggregated based on decision-level 
variables. Settlements are identified through the issuance of Desistments or Revocation 
orders, in which the court acknowledges that the charges are dropped by the claimant. 
5.4 The Netherlands 
The dataset for the Netherlands was collected and constructed in the same way as the 
French dataset, with two main differences. First, one court has exclusive jurisdiction over all 
patent cases in the Netherlands throughout our period of interest: the Court of The Hague 
(s’Gravenhage). 
Second, in contrast to France, in the Dutch system there is almost no automatic release of 
court records once a case is filed (e.g. ordonnances de mise en état). Neither is there a court 
diary as in the case of the PHC in England and Wales. As a result, our dataset may miss a 
substantial number of cases that were settled before any court decision was made, and may 
fail to identify some settlements as the court does not publish anything once a case is 
dismissed. 
5.5 Patent information 
To obtain additional information on litigated patents, we matched the litigation database 
with EPO’s Patstat (version April 2012), which contains data on the German Patent Office 
(DPMA), the UK Intellectual Property Office, the French Intellectual Property Institute (INPI), 
the Dutch Patent Office, and the European Patent Office (EPO). The patent information 
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extracted from Patstat includes information on application dates, IPCs, applicants and 
inventors, equivalents, forward and backward references. We rely on legal status 
information from Patstat to identify the countries in which an EPO patent was validated. 
5.6 Litigant information 
We combine the information obtained from court records with detailed information on the 
parties. The names of the litigating parties were matched to firm-level databases including 
Compustat, Bureau van Dijk’s FAME (UK), AMADEUS (Europe), QIN (China), and the ICC 
British Company Directory (UK) in order to obtain information on firms’ characteristics and 
financials. 
5.7 Identification of cases litigated in multiple jurisdictions 
To identify parallel cases, we proceed as follows. We use all available patent numbers of 
court cases in all four countries and construct their patent families to obtain German, UK,138 
Dutch, French, as well as EPO equivalents.139 
We then match patent families across the four jurisdictions to identify patents litigated in 
several jurisdictions. In case we found a patent (family) to be involved in disputes in more 
than one jurisdiction, we also cross-check litigating parties’ names to ensure the assignee is 
the same (either as claimant or defendant). For example, we consider a case where patent X 
is litigated in jurisdiction Y by parties A and B to be parallel to a case in jurisdiction Z where 
patent X is litigated by parties A and B.  
The search for parallel cases is partly facilitated by data that we collected from UK court 
records that provide information on the existence of parallel cases outside of the UK, 
including Germany, France, and the Netherlands. This information is only available when 
judges refer explicitly to parallel cases in their judgments. Hence, this information is far from 
complete. It nevertheless provides additional information that we use to assist the 
identification of parallel cases.  
5.8 Comparison sample 
We also draw on Patstat to construct a control sample of patents and utility models that 
have not been litigated. The control sample consists of non-litigated patents and utility 
models that share the same priority year, priority filing authority, and IPC subclasses with 
litigated patents. This control sample allows us to compare the characteristics of litigated 
patents and utility models with those of patents that were not subject of litigation at the 
invention level (the priority filing). 
                                                        
138
 Note that we do not have patent data for all cases (for example in the case of the UK, we have data for only 
65% of all cases). 
139
 We use the extended INPADOC patent family definition in Patstat. 
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5.9 Case counts 
Counting court cases and comparing case counts across jurisdictions is a challenge because 
of the differences in litigation systems described above – notably a bifurcated vs. a non-
bifurcated system – as well as procedural differences. However, also missing data poses a 
challenge. To still allow for a meaningful comparison, we present case counts using a 
number of different ways of counting cases and using different assumptions about missing 
information. Table 1 summarizes the different ways in which we count cases. In Table 1, 
gray shaded cells indicate that the data necessary to adjust case counts is available in a 
given jurisdiction, whereas white cells mean the data are not available and black cells mean 
the adjustment is not applicable in a given jurisdiction. 
For each jurisdiction, we count all available patent cases regardless of the underlying claim. 
Since we are primarily interested in infringement and revocation cases, we also compute 
case counts when limiting case counts to those claims. Further, we adjust the number of 
cases for missing data due to courts not covered by our data collection in each jurisdiction. 
In Germany, this concerns nine LGs, in the UK this concerns the PCC, and in France 9 TGIs. 
No such adjustment is necessary for the Netherlands as there is only a single court that 
hears patent cases. Since only the German data includes utility models, we also provide case 
counts when we restrict the data to cases involving invention patents.140 
As described above, cases that involve several patents are often split by courts in in 
Germany such that there are separate case numbers for each patent. One way of accounting 
for this is to assume that one patent corresponds to one case. Hence, we count each case 
once for each patent that it involves. Another way to adjust the data for this problem is to 
consolidate actions that can be assumed to belong to the same case. The consolidation 
includes different actions that occur at the same time (e.g. there are different case numbers 
of each patent in cases that involve several patents) as well as actions over time (e.g. an 
application for a preliminary injunction and the final judgment). This means we consolidate 
the data to also account for the possibility that several separate actions are recorded which 
in reality form part of the same case. 
As discussed in Section 5.2 above, since we collect the data for the UK principally from the 
court diary, cases that settle before they are scheduled for a CMC or a hearing are not 
covered by our data. To make the data comparable, we drop all cases in Germany that also 
settled very early on before the court takes action on the case.  
Finally, in the German bifurcated system infringement and revocation cases constitute 
separate cases even when the revocation case is a direct reaction to the infringement case 
(or vice versa). One way to replicate this set-up in a non-bifurcated system is to count 
                                                        
140
 Note that utility models are widely used in Germany and can also be used as substitutes for invention 
patents. Hence, it is possible that an invention patent covers a given invention in France whereas the same 
invention is covered by a utility model in Germany. 
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counterclaims for both revocation and infringement as separate cases. These data are 
available only for the UK.  
          
Table 1: Modifications of case counts 
Adjustment DE UK FR NL 
     
Only infringement and revocation claims         
Missing cases (courts not covered)*         
Only invention patents         
Cases counted once per patent         
Consolidated at case-level         
Eliminate early settled cases         
Count counterclaims for revocation and 
infringement as separate cases         
          
     
 
  applicable 
 
 
  not applicable 
 
 
  data not available 
 
     Notes: * 9 LGs  not covered in DE, PCC not covered in UK, 9 TGIs not covered in FR 
 excludes utility models for DE 
 Use average number of patents for UK where for 35% of cases patents are not available 
 For UK, NL, FR cases available only at the consolidated level 
In UK cases settled before CMC scheduled not covered -- exclude cases in DE that settled 
within 42 days after receipt of claim. 
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6 Comparison of patent litigation in UK, Germany, France and the Netherlands 
This section presents the results of our analysis. We compare patent cases across Germany, 
the UK, France and the Netherlands. We separate our analysis into the case-, litigant-, and 
patent-level. 
6.1 Case-counts 
Table 2 shows the total of patent cases for all four jurisdictions over the period 2000-2008.  
                    
Table 2: Case overview 
Year 
claim 
filed 
Jurisdiction 
 DE FR NL UK‡ Total 
DU MA MU 
BPatG 
(revocation) Total         
2000 279 97 21 171 568 106 42 19 735 
2001 321 129 33 165 648 126 40 22 836 
2002 3 139 37 129 308 125 31 24 488 
2003 310 148 62 144 664 85 19 28 796 
2004 436 205 59 170 870 120 45 27 1062 
2005 492 197 47 196 932 118 40 28 1118 
2006 383 189 45 197 814 129 35 40 1018 
2007 477 249 69 195 990 106 36 31 1163 
2008 437 209 48 251 945 87 38 37 1107 
          Total 3,138 1,562 421 1,618 6,739 1,002 326 256 8,323 
  
 
                
DU: Düsseldorf; MA: Mannheim; MU: Munich; BPatG: Federal Patent Court 
* Missing case files at the regional court in Düsseldorf for the year 2002 
‡ England and Wales 
 
By far the largest number of cases is heard by German courts. Of the total of 6,739 cases in 
Germany, 5,121 are infringement cases heard by the three regional courts covered by our 
study whereas 1,618 are revocation cases heard by the BPatG. 683 of these revocation cases 
are reactions to infringement suits in our period of observation. By far the largest number of 
infringement cases is heard by the regional court in Düsseldorf (3,138 cases). Mannheim 
comes second with less than half as many cases (a total of 1,562 cases), while the regional 
court in Munich has heard only 421 cases over the entire 2000-2008 period.141 Table 2, 
therefore, suggests that Düsseldorf has the largest number of patent cases in Europe. For 
decades the Düsseldorf regional court has been for the primary court for patent 
                                                        
141
 The low number in Munich is partly due to missing documents in the court archive and the deletion of court 
records. 
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infringement cases in Germany (Stauder 1983; Hase 1992; 1993; 1994). Its technical 
expertise and reputation presumably make it an attractive choice for claimants. Note that 
the dip at the Düsseldorf court in 2002 is due to the deletion of case files from the 
archive.142 All older documents, going back to 2000, could be retained. 
Table A1 in the appendix shows case counts for Germany if we use alternative ways of 
defining a case (see Table 1 for an overview). If we restrict the case count to cases that claim 
infringement or invalidity, the count falls by around 8% to 6,220. In contrast, if we adjust the 
count for the fact that we covered only the three most important regional courts, case 
counts jump up to 8,809. Next, we systematically count each case once for each patent that 
is at issue (e.g. a case with three patents is counted three times). As shown in Table A1, this 
way the number of cases increases from 6,739 to 8,134 (an increase of 30%). This 
underscores that not all German courts do systematically split cases according to the 
number of patents involved. Reducing the case count to cases that only involve invention 
patents means the count drops to 3,700. However, given the widespread use of utility 
models in Germany, often as a substitute to invention patents, looking only at invention 
patent cases might be too narrow a focus. Perhaps the most direct comparison with case 
counts from the other jurisdictions is shown in Column [F] of Table A1. It shows 
consolidated case counts and hence accounts for any potential over-counting due to case-
splitting. The resulting case count is only slightly less than 70% of the original count. Finally, 
we drop all cases that settled very early on, essentially before the court took any action 
(within 42 days counting from the filing date of the claim, which is the period where parties 
had to file their first response to the court). This accounts for the concern that such cases 
might be missing from the UK case count. However, we see that the number of cases that 
drop out at such an early stage of proceedings is very low in Germany. 
We find the lowest number of cases in the UK with only 256 cases over the 9-year period. 
There is a moderate increase in filings over the period covered, but the case count in 2008 is 
still only 37. Table A2 in the appendix shows case counts for the UK after making different 
adjustments. When we add the available data for the PCC in 2007 and 2008, we see that the 
case count increases by slightly less than 20%. Nevertheless, if we assume that the PCC 
heard on average 20% of patent cases during 2000-2008, the total case count would 
increase to 307. Column [D] shows that if we counted each case once per patent at issue, 
we would end up with a count of 363 cases. Mimicking a bifurcated system, Column [E] 
counts counterclaims for infringement and invalidity as separate cases. This results in a total 
count of 356. One might argue that combining [D] and [E] produces a case count that is 
most directly comparable with the German figures. However, as discussed above, this is not 
entirely true because in Germany cases are not systematically split according to the number 
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 The drop of cases in Germany in 2002 is due to an internal decision at the regional court in Düsseldorf to 
remove and destroy files and only store decisions in the court archive. 
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of patents at issue. In any case, even if we combine [D] and [E], the total case count reaches 
only slight more than 500 cases.  
The total caseload in France is 1,002. In contrast to Germany and the UK, there is no 
increase in case filings over time. Due to more limited data, Table A3 in the appendix shows 
only a few variations of the case count for France. Multiplying case counts by the number of 
patents involved (Column [D]) results only in a modest 10% increase in case counts. 
However, adjusting for cases that were heard by courts not covered by our data, we obtain 
a count of 1,503 cases. 
Finally, the caseload in the Netherlands with 329 cases is only slightly larger than in the UK. 
Since all cases are heard by a single court, in principle, no adjustment for missing cases is 
needed. If we count cases once for each patent at issue, the case count increases to 339 
cases. 
In summary, depending on how we count cases, Germany has between 12 and 29 times as 
many cases as the UK. The difference is similar with regard to the Netherlands. Compared to 
France, Germany has around six times as many cases. Hence, although there are important 
differences in case counts depending on how cases are defined, the number of cases hard 
by German courts by far exceeds the combined number of cases in all three other 
jurisdictions.  
6.2 Case-level analysis 
Table 3 cross-tabulates claims and information on whether a cases ended with a court 
decision. We distinguish between infringement and invalidity claims and an “other” 
category that contains other types of patent related claims such as entitlement, royalty 
payments etc. There are some interesting differences both within and across countries with 
regard to whether a case ends with a judgment on the merits. 
In France and Germany there is hardly any difference between the settlement rate of 
infringement and revocation cases (the settlement rate is approximately 100% minus the 
share of cases decided by judgment). In the UK, interestingly, a larger share of revocation 
than infringement cases is litigated through to judgment. In the Netherlands, almost all 
infringement cases are decided by the court, but only half of revocation cases are. However, 
the data for the Netherlands should be interpreted with caution. It is likely that some 
settled cases are missing from the data, which would help explain the unrealistically large 
share of adjudicated infringement cases.  
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Table 3: Case outcome and duration, 2000-2008 
Jurisdiction 
Final Judgement 
reached Duration in months* 
  Claim # Cases % Mean Median Mean Median 
        
DE 
infringement 1,982 37.5% 11.5 9.2 
  revocation 1,107 37.2% 18.2 15.0 
  other 887 31.5% 15.1 13.8 
  
      
No 
counterclaim** 
UK‡ 
infringement 68 62.4% 11.7 11.0 8.6 11.0 
revocation 59 72.8% 10.8 11.2 10.3 11.2 
other 20 66.7% 10.0 8.2 13.0 8.2 
        
FR 
infringement 704 83.7% 23.5 19.8 
  revocation 56 82.4% 19.4 19.8 
  other 151 68.3% 16.8 19.8 
  
        
NL 
infringement 254 97.3% 13.9 9.8 
  revocation 40 49.4% 17.2 11.4 
  other 0 0.0% na na 
                  
* Computed as difference between date when case was filed and first judgment. 
** Restricted to cases where either infringement or revocation at issue (no invalidity defense or 
counterclaim). 
Other claims include disputes over employee inventions, royalty payments, the ownership of 
patents etc.  
‡ England and Wales 
      
 
 
There are also substantial differences between jurisdictions: in Germany less than 40% of 
infringement and revocation actions end with a judgment on the merits, the share in France 
is more than twice as large (although again caution is in order in interpreting the data for 
France). Also settlement rates in the UK and the Netherlands are a lot lower than in 
Germany regardless of the claim brought by claimants.  
Table 3 also shows average and median durations of cases until a first judgment on the 
merits of a case is handed down. We choose the first enforceable decision on the merits of 
the case to ensure time lags are comparable across jurisdictions. Decisions to appeal are 
endogenous to the differences in appeal procedures across countries. 
The figures suggest that the median duration of an infringement case is shortest in Germany 
(9.2 months), followed by the Netherlands (9.8 months), and the UK (11 months). 
Infringement cases take a lot longer in France (19.8 months). Invalidity actions take a lot 
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longer to decide in Germany (15 months) than in the UK (11.2 months) and the Netherlands 
(11.4 months). Again, invalidity cases in France take significantly longer (19.8 months) than 
in any other jurisdiction.  
The relatively fast decisions in infringement cases in Germany could be the outcome of 
courts focusing on the issue of infringement, relying on the assumption of validity. We have 
data on counterclaims for the UK that allow us to compare the duration of cases in the UK 
where only infringement or revocation were at issue (i.e. no counterclaims). However, the 
defendant’s decision not to file a counterclaim is obviously an endogenous choice which 
means that the set of cases where no counterclaim is filed might have characteristics that 
are correlated with the duration of the case (and hence the figures may not be reliable). 
Regardless, Table 3 shows that the case length for cases where only either infringement or 
revocation were at issue does not differ relative to the broader set of cases that includes 
counterclaims (emphasis should be put on the median duration due to the small number of 
observations). 
Table 4 cross-tabulates claims and their corresponding outcomes. There are large 
differences across jurisdictions with regard to case outcomes. 
                    
Table 4: Outcomes for infringement and revocation claims 
Claim  
Outcome 
 
Infringed Not infringed Revoked Settled 
  # % ** # %** # %** # % 
Infringement DE 1165 22.0% 521 9.9% 296 5.6% 2,434 46.1% 
 
FR* 47 5.6% 630 74.9% 27 3.2% 137 16.3% 
 
NL* 94 36.0% 137 52.5% 23 8.8% 7 2.7% 
 
UK‡ 16 14.7% 11 10.1% 28 25.7% 36 33.0% 
          Revocation DE 208 7.0% 298 10.0% 574 19.3% 1059 35.6% 
 
FR* 0 0.0% 45 66.2% 11 16.2% 12 17.6% 
 
NL* 0 0.0% 11 26.8% 29 70.7% 1 2.4% 
 
UK‡ 3 3.7% 15 18.5% 34 42.0% 21 25.9% 
                    
* Data not available or incomplete for FR and NL. 
      ** percent of decided cases 
       
 
‡ England and 
Wales 
        
 
 
In Germany, about a fifth of infringement cases that end with a decision ends with the judge 
holding a patent infringed (regardless of whether the patent is eventually held invalid by the 
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BPatG).143 This share is a lot larger in the Netherlands (36%). In France, in contrast, only a 
small share (5.6%) of patents is held infringed (of cases that end with a judgment). Most 
patents are held valid (including cases where validity was not challenged) but not infringed. 
One explanation could be that a saisie-contrefaçon reveals that patents are stronger than 
assumed and potential claimants fail to pursue the case further (See Section 3.3). 
In the UK, the large share of revoked patents of cases that allege infringement is striking. 
Helmers and McDonagh (2013a) show that in about 60% of cases alleging infringement, the 
defendant counter-claims for revocation. This helps explain the relatively large share of 26% 
of infringement cases that end with revocation. The relatively lower share of infringement 
cases (that are decided by judgment) in Germany that end with revocation has to be 
interpreted with caution, however. Only around a third of alleged infringers file a claim for 
revocation with the BPatG. This partly explains why the share of allegedly infringed patents 
that are eventually revoked is a lot lower in Germany than in the UK.  
Also outcomes of invalidity actions differ considerably across jurisdictions. Whereas in the 
UK 42% of patents are revoked if the case if decided by the judge, less than half as many 
invalidity cases end with revocation in Germany and France. The table also shows that the 
risk of infringing a patent that forms the subject of a revocation action is very low in all 
jurisdictions (4% in the UK and 7% in Germany). 
Table 5 looks at appeals. Data on appeals are only available for the UK and Germany. We 
show the share of cases that was appealed from the first instance (the PHC in the UK and 
the regional courts on infringement and the BPatG on revocation in Germany) and then 
heard by the Court of Appeal and the Supreme Court/House of Lords in the UK or the Higher 
Regional Courts (for appeals from the regional courts in infringement cases) and the Federal 
Court of Justice (for appeals from the higher regional courts in infringement cases and 
appeals from the BPatG in revocation cases) in Germany. 
The table shows that only a small fraction of infringement (15%) and revocation (10%) 
decisions are appealed in Germany. In the UK, the share of decisions appealed at the Court 
of Appeal is around 46% for both infringement and revocation decisions. The share of 
decisions for revocation cases that are overturned by the Court of Appeal and the higher 
regional courts is similar in the UK and Germany (slightly less than 30%). Only a very small 
                                                        
143
 In Germany some infringement proceedings contain more than one patent and all of the patents could be 
challenged individually in multiple revocation proceedings. This means that we summarize case outcomes such 
that there is only a single outcome for potentially several revocation cases corresponding to an infringement 
outcome. If there were more than one revocation proceeding on one particular patent with varying outcomes, 
we used the latest available outcome. If there were different outcomes in revocation proceedings on several 
patents that were all related to a single infringement case, we defined the outcome "revoked" when at least 
one patent was revoked. If there were multiple outcomes for the different patents, we always chose the court 
decision if available instead of a settlement (i.e. if one patent revocation action was settled and the other 
decided with a revocation, we code the case outcome as revocation). 
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number of cases proceed to the Supreme Court or the BGH (infringement cases).144 Cases 
heard by the Supreme Court and the BGH involve fundamental question of the law and 
usually have importance beyond the issues at stake in a given case.145 
                
Table 5: Share and outcome of appeals 
  
1st Instance 2nd Instance 3rd Instance 
Country Claim 
judgment # cases 
% 1st 
instance 
% 
overturned 
# cases 
% 2nd 
instance 
DE infringement 1982 298 15.0% 11.1% 13 4.4% 
 
revocation** 1107 114 10.3% 29.8% 
  
        UK‡ infringement 69 32 46.4% 18.8% 3 9.4% 
 
revocation 59 27 45.8% 29.6% 4 14.8% 
                
* Data not available for FR and NL. 
     ** The 2nd and final instance is the Federal Court of Justice (BGH). 
   ‡ England and Wales 
       
Our data also allow us to identify cross-border litigation, that is, cases that were litigated in 
multiple jurisdictions. That is, the same patent and the same claimants/defendants are 
involved in separate court cases in different jurisdictions. Table 6 tabulates the number of 
parallel cases across the four jurisdictions. 146 Because patents granted under the EPC turn 
into national property rights, they have to be enforced and invalidated in each jurisdiction 
separately (Articles 2 and 64(3) of the EPC). This raises concerns regarding the efficiency and 
costs of the system. Even more worryingly, despite the fact that all national parts of an EP 
have (at least initially)147 the same claims, court outcomes have often differed across 
jurisdictions.148 
  
                                                        
144
 For revocation cases in Germany, there is only one court of appeal, the Federal Court of Justice and hence 
the 3
rd
 instance cells in Table 5 are empty. 
145
 See Helmers and McDonagh (2013a), p. 1455 for a discussion of the cases heard by the Supreme Court in 
the UK. 
146
 This analysis is conducted on the patent level accompanied by identification of at least one common litigant 
in each of the jurisdiction. 
147
 After the opposition deadline has lapsed, the national parts of an EP patent can only be attacked separately 
before the national courts. Therefore, the claims of the national parts of the EP might change during these 
proceedings when certain claims are revoked. 
148
 Mejer and van Pottelsberghe (2012, p. 226-232) report several case studies showing the diverging 
(inconsistent) decisions in different European jurisdictions regarding the same patent. Perhaps the most well-
known case is that of Epilady v. Remington where infringement of Epilady’s patent was found in Germany and 
the Netherlands but not in the UK and France. 
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Table 6: Parallel cases* (2000-2008) 
  DE FR NL UK‡   
cases with 
parallel 
case** 
total 
cases** share 
Parallel cases (same patent, either same claimant or defendant) 
DE   102 71 61 
 
1,009 6,427 16% 
FR 816   33 27 
 
113 840 13% 
NL 517 31   38 
 
92 302 30% 
UK‡ 505 24 41   
 
84 165 51% 
Parallel cases (same patent & same claimant and defendant) 
DE   34 24 21 
 
127 5,121 2% 
FR 68   16 13 
 
51 840 6% 
NL 46 16   18 
 
44 302 15% 
UK‡ 35 14 19   
 
43 166 26% 
                  
* Based on patent numbers 
** For which patent numbers available 
‡ England and Wales 
§ Exceeds number of cases where patents are available because 1 cases was retrieved from 
references in UK court records to parallel cases in other jurisdictions. 
 
Table 6 shows parallel cases according to two definitions as explained in Section 5.7 above. 
The first type of parallel cases is less restrictive and means that the assignee of a patent is 
involved in law suits in several jurisdictions with potentially different adversaries. The 
second definition only captures cases where the claimant and defendant face each other in 
multiple jurisdictions over the same disputed patent. Table 6 shows that the share of 
parallel cases is considerably larger for the broad definition of parallel cases. But even when 
we restrict the set of cases to the second, more restrictive definition, we still find for the UK 
and the Netherlands a relatively large share of cases that are litigated in several jurisdictions 
(26% in the UK and 15% in the Netherlands). Conversely, the rate of duplication among 
patents litigated in Germany is tiny (2%). However, the number of cases in the UK and the 
Netherlands is considerably lower than in Germany, which determines the upper bound for 
the share of duplicated cases in Germany.149 
The larger share of duplicative cases in the UK and the Netherlands is partly explained by a 
considerably larger share of EPO patents among litigated patents that have also entered into 
force in the other three jurisdictions. This is shown in Table 7 which lists the share of 
litigated patents according to the patent office that published/granted the patent right. 
Domestic patents account for 58% in Germany but for only 16% in the UK. The table also 
                                                        
149
 Roughly, even if every case litigated in France, the Netherlands, and the UK were duplicated in Germany, 
the share of duplicated cases would not exceed 25%.  
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shows the share of litigated EP patents that was validated in any of the four jurisdictions.150 
The figures reveal that most EP patents are validated in all four jurisdictions. The highest 
validation rate is found for Germany (93% on average), which reflects the relatively large 
market size of the German economy within Europe. The lowest validation rate (63%) is 
found for the Netherlands, which again reflects the relative (lower) importance of the Dutch 
economy. The large share of patents validated in all four jurisdictions underscores the 
fragmentation of the European patent system. While the same patent right is granted in 
several European jurisdictions, it has to be litigated in each jurisdiction separately. 
                
Table 7: Patent type and national validations 
 
Domestic EPO Other 
 
% % Also validated in % 
      DE FR NL UK‡   
        DE 57.6% 42.4%   88.6% 57.7% 85.5% 0.0% 
FR 58.8% 38.7% 89.3%   59.6% 84.3% 2.5% 
NL 25.8% 72.6% 96.0% 91.7%   89.9% 1.6% 
UK‡ 16.2% 80.6% 94.8% 96.0% 72.4%   3.2% 
                
‡ England and Wales 
Note: validations in country where a patent is litigated may be less than 100% because in 
some cases, patents that have not yet been granted are subject to litigation. 
 
 
6.3 Litigant-level analysis 
Next, we take a look at the characteristics of parties involved in the patent cases. Figure 6 
looks at the nationality of litigants at the case-level. We distinguish between domestic and 
foreign litigants.151 The figure shows that half of all cases involve only domestic claimants in 
Germany and France. The share of cases with only domestic claimants drops below 40% for 
the UK and the Netherlands. The data look similar for defendants, with the exception of 
Germany where the share of cases with only domestic defendants exceeds 60%. 
  
                                                        
150
 We use legal status information to distinguish designation from validation; hence, we are able to tell 
whether a patent that was granted by the EPO became effective in an EPC member state. 
151
 The nationality of a litigating party was obtained in two ways. For companies that were matched to any of 
the firm-level datasets discussed in Section 5.6, the nationality was determined based on the firm-level data. 
We searched for the nationality of all other litigants manually online. 
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Figure 6: Nationality of claimants/defendants 
 
‡ England and Wales 
 
Figure 7 shows a breakdown of litigants by type, where we distinguish between companies, 
individuals, and others, where the latter category comprises universities, public research 
institutes, government, as well as international institutions/organizations (such as the 
European Central Bank). The largest differences in the shares of companies and individuals 
involved in patent cases are found across jurisdictions rather than between claimants and 
defendants – perhaps with the exception of France where there are almost twice as many 
individuals as defendants than there are claimants. Overall the share of companies as 
claimants or defendants is smallest in Germany. The large number of individuals involved in 
lawsuits may indicate that a large number of small companies (where owners appear in 
court) or inventors (as co-claimants) are involved in patent actions. We investigate the issue 
of company size further in Figure 8. 
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Figure 7: Type of claimants/defendants 
 
‡ England and Wales 
 
Figure 8 shows a breakdown of corporate litigants by size category: micro and small, 
medium-sized and large. Since companies are allocated into the size categories based on 
employment data, total assets, or turnover, the table is limited to companies that report at 
least one of those variables. There are some notable differences across jurisdictions. The 
greatest share of litigants in the UK falls into the “large” category. This reflects the fact that 
disproportionately many pharmaceutical companies litigate in the UK (see next paragraph) 
and the fact that litigation at the PHC is relatively expensive.152 In all other jurisdictions, 
micro- and small companies represent the largest share of litigants. In France and the 
Netherlands, the share of small companies even outstrips the combined share of medium-
sized and large companies. 
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 Helmers and McDonagh (2013b), p. 384. 
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Figure 8: Size of claimants/defendants 
 
‡ England and Wales 
 
Figure 9 shows a breakdown across broad sectors. A few things stand out. First, the share of 
pharmaceutical companies in the UK of 30% exceeds the share of pharmaceutical 
companies involved in patent litigation in any other jurisdiction. This confirms the widely 
held view that the UK is an important venue for pharmaceutical patent litigation in Europe. 
This is probably partly explained by strong, ongoing disclosure requirements and the 
important role attributed to expert witnesses in High Court proceedings. In Germany, in 
contrast, companies are concentrated in manufacturing, notably the machinery and engine 
industry, which comprises a wide range of engineering-based industries. In the Netherlands, 
the share of companies in the services industry (especially finance, insurance, and real 
estate) stands out. 
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Figure 9: Sector distribution of claimants/defendants 
 
‡ England and Wales 
 
6.4 Patent-level analysis 
It is well known in the literature that patents in certain technology areas, notably complex 
technologies such as digital data transmission, are far more likely to be involved in litigation. 
Table 8 shows a breakdown of litigated patents across five broad technology areas. The 
most striking difference is the share of cases involving chemical/pharmaceutical patents 
heard by the PHC in the UK and the regional courts in Germany (31% compared to 19%). The 
share of patents in mechanical engineering is relatively large for Germany (33%) and the 
Netherlands (38%). 
The share of patents related to electrical engineering, which comprises ICT related 
technologies, is remarkably large for the UK (26%). Since these technologies have recently 
received a large amount of attention due to litigation involving so-called patent trolls, and 
the “patent wars” between the giants in the smartphone industry such as Google, HTC, 
Nokia, or Microsoft, we provide a breakdown of this broad category. The detailed 
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breakdown reveals that the large share in the UK is largely due to patents on digital data 
transmission and telecommunication. The share of patents in these technologies is relatively 
low in Germany.  
      Table 8: Technology classes of litigated patents 
  
Share of technology (based on IPCs) 
    DE FR NL UK‡ 
            
Electrical engineering 
 
15.4% 18.2% 9.1% 25.8% 
 
Electrical machinery, energy 26.5% 24.6% 17.5% 6.2% 
 
Audio-visual technology 20.9% 24.6% 36.8% 14.0% 
 
Telecommunication 12.4% 7.3% 8.8% 24.8% 
 
Digital communication 10.8% 12.6% 5.3% 27.1% 
 
Basic communication processes 5.6% 3.0% 10.5% 7.0% 
 
Computer technology 16.5% 21.8% 14.0% 15.5% 
 
IT methods for management 1.7% 4.9% 5.3% 5.4% 
 
Semiconductors 5.7% 1.2% 1.8% 0.0% 
Instruments 
 
13.6% 12.8% 14.3% 15.4% 
Chemistry 
 
18.6% 21.8% 25.5% 31.1% 
Mechanical engineering 
 
33.4% 28.8% 38.1% 18.7% 
Other* 
 
19.0% 18.3% 13.0% 9.0% 
            
* Contains furniture and games, other consumer goods, and civil engineering. 
‡ England and Wales 
      
To gain additional insight into the characteristics of the set of litigated patents, we compute 
a number of patent characteristics that are commonly interpreted as proxies for the breadth 
and value of patents in the literature.  
         Table 9: Comparison litigated patents across jurisdictions 
 
Mean Std. Dev. 
DE FR NL UK‡ DE FR NL UK‡ 
  
Backward citations 2.49 3.22 2.78 4.19 3.32 3.61 3.73 4.42 
Forward citations 5.08 2.00 2.28 3.94 12.45 4.63 4.87 13.59 
Non-patent references 0.57 0.66 0.89 1.26 1.65 1.34 1.42 3.72 
Family Size* 8.07 8.92 14.81 20.35 11.28 12.68 17.36 21.15 
Number of inventors 1.72 1.84 2.04 2.84 1.47 1.59 1.83 2.20 
Number of IPC Subclasses 1.91 1.90 2.11 2.55 1.25 1.28 1.59 1.71 
                  
* Defined according to EPO'S DOCDB family definition. 
     ‡ England and Wales 
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Table 9 suggests that patents litigated in the UK are most valuable (measured by a 
combination of family size, forward citations, and the number of inventors). If the number 
of IPC subclasses is interpreted as a measure of patent breadth, patents litigated in the UK 
are considerably broader than the patents litigated in any of the other jurisdictions. 
Moreover, the number of non-patent references that are cited by a patent suggests that 
patents involved in court cases in the UK are potentially more closely related to scientific 
discoveries. This may simply reflect the large share of pharmaceutical patents among all 
litigated patents in the UK. In any case, the figures support the view that cases litigated in 
the UK involve particularly valuable inventions which justify the relatively more expensive 
litigation costs. 
To allow also for a comparison of the litigated patents relative to a set of similar, but un-
litigated patents, we draw a control sample of patents that have not been involved in 
litigation and that match litigated patents with respect to the type of IP (invention patent or 
utility model), priority filing year, filing authority and the IPC subclasses – i.e. that protect 
similar technologies. The results are shown in Table 10. 
                
Table 10: Comparison litigated vs. non-litigated patents 
 
Mean Std. Dev. T-test* # Obs.  
Litigated Control Litigated Control difference Litigated Control 
Backward citations 2.77 0.94 3.34 2.14 -67.38 7,667 80,764 
Forward citations 5.01 1.42 13.12 5.62 -45.39 7,667 80,764 
Non-patent references 0.63 0.35 1.75 1.37 -16.38 7,667 80,764 
Family Size** 8.43 11.59 11.68 12.07 21.98 7,667 80,764 
Number of inventors 1.98 3.05 1.44 2.24 38.30 6,739 67,684 
Number of IPC Subclasses 1.91 1.11 1.26 0.36 -0.01 7,667 80,764 
      
Non-litigated control patents and utility models matched to litigated patents and utility models on priority filing year 
and authority as well as IPC subclasses. 
* All differences are statistically significant at <5% level. 
     ** Defined according to EPO'S DOCDB family definition. 
      
Table 10 compares the entire set of litigated patents to a set of control patents that protect 
inventions similar in terms of priority year, priority filing office, as well as the patent’s IPC 
classes. We find that the number of forward citations received worldwide is significantly 
higher for the litigated patents compared to the group of non-litigated patents. As forward 
citations are generally considered an indicator for patent value we find support for the 
conjecture that litigated patents constitute particularly valuable patents. This result is 
somewhat contradicted by the family size variable, indicating the number of countries the 
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patent has been applied for.153 Again, if the number of IPC-classes covered by the patent is 
interpreted as a broad measure of patent scope, we see that patent scope is significantly 
larger for litigated patents. This can be explained by the fact that infringement is more likely 
if the patent has a broader applicability and thus more potential infringers. Regarding two 
different measures of the extent to which the patent relies on prior art, we find both the 
number of backward citations and the number of non-patent backward citations (denoting 
closeness to basic academic research) to be significantly higher for the litigated patents. A 
surprising result is that the litigated patents on average have a lower number of inventors 
than the non-litigated patents. 
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 Family size is measured by using the broad DOCDB family definition in EPO’s Patstat. 
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7 Conclusion 
The European patent system is currently undergoing fundamental changes. The institutional 
reforms that are being implemented are controversial. The discussions concerning the 
reforms of the European patent system, and especially the discourse regarding changes to 
the legal and procedural framework of patent enforcement have been characterized by a 
striking lack of representative quantitative evidence. Our analysis seeks to contribute to the 
debate new and comprehensive empirical evidence based on a novel dataset covering 
patent enforcement in the four most important jurisdictions in Europe: Germany, UK 
(England and Wales), France, and the Netherlands.  
For a variety of legal and procedural reasons, European legal systems are not set up to 
provide easy access to case information. Therefore, these data had to be collected from a 
wide range of sources, including information from handwritten case records at regional 
courts in Germany, online case repositories and private data providers. Being the first study 
of this kind, we developed a methodology that allowed us to transform largely qualitative 
information collated from court records into quantitative measures that are comparable 
across jurisdictions. The analysis of this novel dataset uncovers a number of interesting 
differences in patent litigation patterns across the different jurisdictions.  
With respect to the results of the study, we show that the number of cases heard by 
German regional courts exceeds by far the number of cases heard in the other three 
jurisdictions. Even when we account for the over-counting of cases due to bifurcation, 
idiosyncratic practices at regional courts and procedural differences, the number of cases in 
Germany exceeds the combined number of cases in the other three jurisdictions over the 
same time period. We also demonstrate that the number of cases has increased in the UK 
and Germany over time, but there is no evidence for an upward trend in case filings in 
France and the Netherlands. 
Regarding the settlement of disputes, our analysis also reveals significant differences across 
countries. More than 60% of cases in Germany end with a settlement, whereas this is true 
for only around 40% of cases in the UK. When cases are decided by a judge, outcomes differ 
across jurisdictions. In the UK, revocation is the most likely outcome regardless of whether 
the initial claim is for infringement or revocation. Infringement is most likely to be found by 
German and Dutch courts. In France, the large share of patents that is held not to be 
infringed (but valid) stands out. 
The data also allow us to compare the time it takes to obtain a judgment in the first 
instance. The time lag that lapses between the filing of a claim for infringement and a first 
decision is less than one year in Germany, the Netherlands, and the UK. Infringement cases 
take almost one year longer in France to reach a decision. Claims for invalidity are decided 
fastest in the UK (within less than a year), but take considerably longer in Germany (on 
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average 18 months). Moreover, our evidence indicates that the PHC in the UK does not 
decide faster when there is only either infringement or validity at issue. 
We also obtain insights regarding one of the main motivations for the current reforms of the 
European patent system: fragmentation. We show that most EPO-granted patents that are 
litigated in a given jurisdiction have also been validated in all other jurisdictions (possibly 
with the exception of the Netherlands). This means that there is scope for parallel litigation 
of the same patent in multiple jurisdictions. However, our data reveals that the share of 
duplicated cases (cases that involve the same patent and litigating parties in multiple 
jurisdictions) is low in Germany (2%) and France (6%). Nevertheless, the share attains 26% in 
the UK and 15% in the Netherlands. This provides mixed evidence for fragmentation and the 
resulting need for parallel litigation in multiple jurisdictions. Quantifying the cost of 
duplication that arises from such parallel litigation deserves further work. However, we note 
that the vast majority of patents are litigation only once. 
Our data also allow us to look at the characteristics of the litigating parties across the four 
jurisdictions. We find large shares of claimants and defendants that are domestic entities. 
The share of only domestic entities is largest in Germany (over half of claimants and 
defendants) and smallest in the UK (less than 40%). Most of the litigating parties are 
registered companies, although there is a significant share of individuals involved in the 
disputes, in particular in Germany (24% among claimants and 29% among defendants). 
Looking at the distribution of litigating companies across industries, we note a concentration 
of companies in pharmaceuticals/chemistry and in electronic products in the UK, whereas 
litigating companies in Germany are concentrated mostly in the areas of machinery and 
engines. The distribution of companies across economic activities is also reflected in the 
distribution of patents across technology areas. Most litigated patents in the UK protect 
pharmaceutical and chemical inventions, as well as inventions related to telecommunication 
and digital data transmission. In Germany, most patents are in the area of mechanical 
engineering. 
A few caveats are in order in interpreting these findings and assessing the potential of the 
currently used dataset. First, our data cover only cases that were filed between 2000 and 
2008. It is possible that the case numbers have changed significantly since then. In fact, 
more recent data for the UK for both the PCC and the PHC suggest that case counts have 
increased substantially. In 2012, there were 86 patent cases at the PHC and 162 IP cases at 
the PCC.154 If we assume that approximately 20% of IP cases at the PCC are patent related 
(Helmers and McDonagh, 2013a, Table 1), this would imply that around 30 patents cases 
were filed at the PCC in 2012. Hence, the number of patent cases would have increased 
from 42 in 2008 to 116 in 2012. Moreover, the 2012 data for the PHC suggests that the 
composition of cases has changed; 31 of the 86 PHC cases (36%) involve smartphone 
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 The 2012 PHC data were generously provided by Powell and Gilbert and IPLA. We collected the 2012 data 
for the PCC directly from court records. 
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producers HTC, Nokia, and Apple.155 In the case of Germany, the evidence is slightly less 
conclusive. Kühnen and Claessen (2013, p. 593) suggest that 475 cases have been filed at 
the Düsseldorf court in 2011 (compared to 437 in 2008). Whereas this is a modest increase 
(9%), the increase at the LG Mannheim between 2008 and 2011 is more substantial (27%) 
albeit still relatively modest in absolute terms (56 cases) in light of the large overall annual 
caseload in Germany. Second, and presumably more importantly, the data for France and 
the Netherlands are subject to important limitations. For France, we have at best only 
around 60% of cases and even the set of cases heard at the Paris TGI might be incomplete. 
Similarly, the low settlement ratios at the Hague court in the Netherlands suggest that we 
might be missing cases that were settled. Hence, the figures for France and the Netherlands 
have to be interpreted with caution which is why we emphasize the comparison of Germany 
and the UK. Having said this, statistics that are conditional on adjudication may not be 
affected by this limitation. 
Regardless of these caveats, the provision of our case-level data and our analysis of this data 
shed new light on the extent of patent litigation in Europe and further illustrate how 
enforcement systems vary in the European jurisdictions which account for the lion’s share of 
patent litigation. We hope that the evidence provided here proves to be useful in informing 
the current academic and policy debates on the creation of a unified pan-European litigation 
system. 
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 These cases involve on average 1.4 patents and it appears that the parties filed separate cases for individual 
patents that might be in fact related. This could imply that the case filing behavior at PHC has to some degree 
assimilated the filing behavior at German regional courts. 
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9 Appendix 
                    
Table A1: DE   
 
A B C D E F G H 
Year 
All 
patent 
cases 
Only infringement and revocation Including 
courts not 
covered* 
Cases counted 
once per 
patent*** 
Only invention 
patents 
Consolidated at 
case level 
Drop early settled cases** 
Infringement Revocation Sum 
Not 
consolidated 
Consolidated 
at case level 
2000 568 348 171 519 710 686 243 366 562 361 
2001 648 430 165 595 810 782 332 446 644 442 
2002 308 154 129 283 770 372 110 169 306 168 
2003 664 463 144 607 830 801 374 470 646 453 
2004 870 636 170 806 1,088 1,050 456 637 856 626 
2005 932 633 196 829 1,165 1,125 525 640 921 632 
2006 814 575 197 772 1,018 983 447 542 791 523 
2007 990 726 195 921 1,238 1,195 668 705 939 662 
2008 945 637 251 888 1,181 1,141 545 612 914 583 
Sum 6,739 4,602 1,618 6,220 8,809 8,134 3,700 4,587 6,579 4,450 
* Courts not covered by the survey include: Berlin, Braunschweig, Erfurt, Frankfurt, Hamburg, Leipzig, Magdeburg, Nuremberg-Fürth and Saarbrücken  
** All cases that settled within 6 weeks 
dropped 
       *** Number of cases multiplied by average number of patents per case (1.207) over entire 
2000-2008 period 
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Table A2: UK 
 
A B C D E D+E 
Year All patent cases Only infringement and revocation PCC patent cases 
added* 
Cases counted once 
per patent 
Count counterclaims 
as separate cases** 
 
Infringement Revocation Sum 
2000 19 10 3 13 
 
27 27 38 
2001 22 11 5 16 
 
31 28 40 
2002 24 9 6 15 
 
34 28 40 
2003 28 10 6 16 
 
40 31 44 
2004 27 15 5 20 
 
38 39 55 
2005 28 9 12 21 
 
40 38 54 
2006 40 19 12 31 
 
57 63 89 
2007 31 8 16 24 38 44 44 62 
2008 37 18 16 34 42 52 58 82 
Sum 256 109 81 190   363 356 505 
* Data available only for 2007 & 2008 
       Number of cases multiplied by average number of patents per case (1.418) over entire 2000-2008 period 
  ** Includes only counterclaims for infringement and revocation 
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Table A3: FR 
 
A B C D 
Year All patent cases 
Only infringement and revocation 
Courts not 
covered* 
Cases counted 
once per 
patent*** Infringement Revocation Sum 
2000 106 79 6 85 159 212 
2001 126 89 8 97 189 252 
2002 125 82 7 89 187.5 250 
2003 85 57 3 60 127.5 170 
2004 120 95 8 103 180 240 
2005 118 80 8 88 177 236 
2006 129 103 4 107 193.5 258 
2007 106 81 12 93 159 212 
2008 87 68 7 75 130.5 174 
Sum 1002 734 63 797 1503 1101 
* Courts not covered by the survey include: Lyon, rennes, Lille, Marseille, Bordeaux, Strabourg, Toulouse, Nancy, 
Limoges, Autres 
 *** Number of cases multiplied by medium number of patents per case (2.00) over entire 2000-2008 period 
                   
 Table A4: NL         
 
 
A B C 
 
Year All patent cases 
Only infringement and revocation Cases counted 
once per 
patent*** 
 
Infringement Revocation Sum 
2000 42 36 3 39 56 
 2001 40 33 1 34 54 
 2002 31 29 1 30 42 
 2003 19 13 4 17 26 
 2004 45 33 8 41 61 
 2005 40 30 7 37 54 
 2006 35 34 1 35 47 
 2007 36 27 6 33 48 
 2008 38 24 9 323 51 
 Sum 326 259 40 299 339 
 
        *** Number of cases multiplied by average number of patents per case (1.345) over entire 2000-2008 period 
 
 
